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ABSTRACT 
 
Drug abuse is strongly influenced by socio-environmental factors. Also, social 
environment is one of the most important predictors for adolescent drug use. In this 
dissertation, I examined how social housing conditions affect morphine reward, 
dependence, and antinociception. I also explored possible mechanisms that may underlie 
these responses. Mice were group-housed in one of two conditions referred to as ‘only’ 
and ‘mixed’. In the only condition, all mice in the cage receive the same treatment and 
are physically and visually separated from mice that receive different treatments (i.e., 
saline only and morphine only). Mice in the mixed condition were housed together with 
mice that received a different treatment- (i.e., morphine cage-mate mice are housed with 
drug naïve mice and saline cage-mate mice are housed with morphine-treated mice).  
Being housed with drug-naive mice conferred a protective effect for the 
rewarding properties of morphine, as well as the occurrence of withdrawal symptoms. 
Similarly, while it did not prevent the development of tolerance to morphine analgesia, it 
did reduce the persistence of this tolerance. Moreover, it provided protection from 
morphine-induced hyperalgesia. Additionally, some of the neurobiological mechanisms 
underlying this protection were identified. Inhibiting the sensation of social grooming in 
morphine cage-mates blocked the protective effect of being housed with drug-naïve 
animals. Additionally, increased expression of vasopressin mRNA was observed in the 
striatum of morphine only animals, while being housed with drug-naïve mice protected 
against this effect. In line with this finding, antagonizing V1b receptors blocked the 
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development of morphine reward in morphine only animals. Lastly, I identified various 
genes with increased expression levels in striatum of morphine only animals, but not 
morphine cage-mates. This makes them potential targets for future studies aiming to 
reveal the underlying molecular mechanisms involved in the protective effects of being 
housed with drug-naïve animals.   These studies further support the notion that social 
conditions alter the propensity for developing opioid addiction, and can be used in the 
development of more efficacious behavioral and pharmacological treatments for 
adolescent opioid addicts.   
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
Addiction is a very pervasive and debilitating disease. More than 20% of 
Americans have used an illicit drug, with many escalating to abuse (National Institutes 
of Health, 2015). Drug addiction is a complex and misunderstood disorder with a wide 
variety of consequences. Among these consequences are problems with health, finances, 
and social relationships.  Aside from these personal consequences, addiction also has 
negative consequences for society.  The estimated annual costs for addiction in the 
United States, which include crime-related costs and costs for health and productivity, is 
greater than $600 billion.  
Addiction is most often defined by compulsive seeking and use of a drug of 
abuse.  Therefore, some individuals may use a drug and not become addicted. 
Unfortunately, many do. There are multiple theories for why some people become 
addicts while others do not. It has been suggested that many people maintain drug use 
because of the drug’s rewarding properties, or to avoid withdrawal (Koob, 1992a, 1992b; 
Koob, Stinus, et al., 1989; Koob, Wall, & Bloom, 1989). Koob and colleagues argue that 
addiction involves the transition from an impulsive to a compulsive state.  In other 
words, while initial use of a drug is due to its positive reinforcing properties, addiction 
arises because of the onset of negative reinforcement.  Another prominent theory, 
proposed by Robinson and Berridge (1993), argues that some users become addicts 
because of the ability of drugs to produce enduring changes in areas of the brain that are 
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implicated in natural reward, and that mediate motivation to seek reward.  Once these 
areas have become ‘hijacked’, they become increasingly sensitive to drugs and related 
stimuli, thus leaving the addict very motivated to seek out these stimuli.  This has been 
termed incentive salience-, or incentive sensitization (Robinson & Berridge, 1993). 
Indeed, drugs of abuse often cause chemical, and structural, alterations in the brain of the 
addict that make abstaining extremely difficult. Most notably, these occur in the 
mesocorticolimbic pathway, and involve regions integral in dopaminergic transmission 
(Hyman & Malenka, 2001). 
 The mesocorticolimbic pathway includes the ventral tegmental area (VTA), 
nucleus accumbens (NAcc), and prefrontal cortex (PFC). Not all drugs of abuse impact 
the brain in the exact same way; however, the contribution of these regions was initially 
observed with psychostimulants, and the evidence for their involvement with 
psychostimulant addiction is convincing. The involvement of the mesocorticolimbic 
pathway in incentive sensitization has been expanded to include other drugs of abuse. 
The classic example of the acute reinforcing effects of drugs of abuse involves 
dopaminergic neurons projecting from the VTA to the NAcc.  Upon acute ingestion of a 
drug, activation of this circuit leads to pleasurable, rewarding effects that become 
associated with the drug. Schultz (2001) showed that, in primates that learned to 
associate a cue with food, dopamine levels were increased when they were presented 
with the cue, but not the food. Therefore, dopamine may also be involved in the 
anticipation to obtain a drug, and not just in its rewarding effects. Often individuals who 
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become addicted no longer report rewarding effects of a drug, but rather withdrawal, 
which may act as a negative reinforcer.  
As previously stated, addiction is characterized by the uncontrollable 
preoccupation and craving for a drug. Once a person becomes addicted to a drug, several 
consequences may arise. For example, there are many medical consequences of drug 
use, including cardiovascular and lung disease, stroke, and cancer.  Addicts may also be 
more prone to illness. Addicts may also abandon their jobs and ignore their 
families/friends. Unfortunately, this leads to a lack of social support, which may further 
propel the addict towards a drug (or multiple drugs). 
Because of the enormous burden on society it creates, it is of great societal 
interest to investigate addiction, in order to potentially determine the neural mechanisms 
that underlie it, so that better treatments and interventions may be developed to treat 
addiction. While addiction can develop at any age, adolescents are in a stage which 
makes them likely to experiment with drugs, which may increase the likelihood of the 
development of addiction (Adriani et al., 2004; Parker & Bradshaw, 2015). Adolescence 
is a period of profound developmental changes. Among these changes are increases in 
risk-taking and novelty-seeking behaviors, which occur in both human adolescents and 
non-human animals (Spear, 2000). Additionally, several physical and cognitive changes 
occur that may increase the adolescent’s susceptibility to delinquent behaviors, including 
drug experimentation. Indeed, adolescence is when most people initiate drug use, as 
statistics show that many addicts report initial drug use between the ages of 12 and 14 
(National Survey on Drug Use and Health, 2008).  Moreover, abuse of opioids, including 
 4 
 
prescription pain medications and heroin, has increased dramatically in this population 
(Johnston et al., 2015), with many more beginning to use every day. In fact, the percent 
of adolescents seeking treatment for heroin dependence has increased from 16.6% to 
25.8% in the past decade, and from 15.5% to 34.5% for prescription opioids (Johnston et 
al., 2015). Currently, there are limited treatment options for adolescent opioid addicts. 
The use of opioid maintenance treatments is usually limited to severe cases in this age 
group. Thus, most treatment regimens for adolescent opioid addicts involve brief 
detoxification, coupled with therapy in outpatient settings (Fiellin, 2008; Subramaniam, 
Fishman, & Woody, 2009). Unfortunately, this approach is often not effective in 
reducing relapse. It has been shown that social support can also be a factor that aids in 
the cessation of use of both licit and illicit drugs (Kelly et al., 2008; Klimas et al., 2014; 
Luchenski et al., 2015; McCutcheon, Luke, & Lessov-Schlaggar, 2016), while lack of 
social support may increase an adolescent’s likelihood of engaging in drug use (Bardo, 
Neisewander, & Kelly, 2013). Similarly, peer support, operationalized as social activity 
in a 12-step program, was shown to increase the length of abstinence in adolescents 
with, and without, social anxiety disorder (Pagano et al., 2015). Nevertheless, more 
effective treatments need to be developed for adolescent opioid users.  
The brain undergoes several modifications during adolescence, and it is 
increasingly recognized that these changes may contribute to adolescent abuse liability.  
Among these developmental modifications are increases in cerebral white matter during 
adolescence (Giedd et al., 1999; Groeschel et al., 2010). The results of these studies 
indicate that there are white matter changes in areas that are implicated in drug craving, 
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seeking, and relapse (for review see, (Van den Oever et al., 2010). Furthermore, the 
immaturity of the adolescent prefrontal cortex in adolescents may contribute to an 
increased susceptibility to drug use. Another modification during adolescence that is 
relevant to drug use is the remodeling of the density and distribution of dopamine 
receptors in the nucleus accumbens (Laviola, Pascucci, & Pieretti, 2001), which may 
result in higher sensitivity to rewards. Indeed, adolescents display heightened activation 
of this area in response to reward-related cues, particularly during reward anticipation 
(Bjork et al., 2004; Ernst et al., 2005; Geier et al., 2010).  Lastly, these modifications in 
the mesocorticolimbic pathway may result in greater salience of social cues in this age 
group (A. R. Smith et al., 2015; Mark A. Smith & Pitts, 2014; van Kerkhof et al., 2013). 
Social interaction has been reported to activate this pathway (van Kerkhof et al., 
2013).  Adolescent rodents interact more with their peers, and exhibit greater affiliative 
behaviors than other age groups, including social play and huddling (Spear, 2000; 
Vanderschuren, Niesink, & Van Ree, 1997).  Moreover, adolescents, but not adults, 
demonstrate riskier behavior, and less cognitive control, in the presence of peers (Chein 
et al., 2011; Gardner & Steinberg, 2005). This increase in risky behavior is accompanied 
by higher preferences for immediate rewards when in the presence of peers (O'Brien et 
al., 2011).  Interestingly, Chein et al. (2011) found that adolescents showed heightened 
activity in the ventral striatum and orbitofrontal cortex – areas implicated in reward – in 
the presence of peers, along with decreased activation of lateral prefrontal cortex – an 
area involved in cognitive control. These patterns of activation likely underlie the fact 
that adolescents engage in riskier behavior in the presence of peers. Lastly, social 
 6 
 
influences are their most powerful during adolescence, and decline with age (Kendler et 
al., 2008). 
Prior research shows that drug use initiation is often influenced by social 
environment (Bardo et al., 2013; Chassin, Hussong, & Beltran, 2009).  In the clinical 
literature, neighborhood environment seems to contribute to the initiation of using drugs 
- as individuals living in an area rife with drug use may be more likely to use illicit 
drugs, including cocaine and heroin (Crum, Lillie-Blanton, & Anthony, 1996; Karriker-
Jaffe, 2011).  It was also shown that heroin overdose fatalities were higher in lower-
income neighborhoods than in higher-income neighborhoods (Cerda et al., 2013). 
Moreover, individuals living in poorer neighborhoods may not develop beneficial 
relationships, as it has been suggested that people in lower-income neighborhoods may 
feel discouraged from developing relationships that might prevent drug use in those 
neighborhoods (Cohen, Farley, & Mason, 2003).  Availability of drugs by interacting 
with peers who use drugs highly correlates with one’s own drug use behavior (Gorsuch 
& Butler, 1976), and problem behavior is often determined by proximal peer influences 
(Patterson, DeBaryshe, & Ramsey, 1989).  Moreover, according to some studies, the use 
of opioids by peers is influential by itself and not only as the source for the opioids 
(Luthar et al., 1992; Yarnold, 1996). Even the mere perception of opioid abuse by peers, 
results in increased initiation of and escalation in opioid use (McDougall et al., 2014).   
Similarly, the animal literature suggests that, in adolescent rodents, the drug 
history of social partners may influence opioid and stimulant taking and seeking 
behavior (H. Chen et al., 2011; Hunt, Holloway, & Scordalakes, 2001; M. A. Smith, 
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Lacy, & Strickland, 2014). In line with human and rodent literature, my laboratory 
demonstrated that housing conditions can alter the behavioral sensitization to morphine 
in adolescent rodents. Specifically, housing with drug-naïve animals reduces the 
development of morphine locomotor sensitization (Hofford et al., 2012). Rodent models 
represent efficacious paradigms for studying human drug use, abuse and dependence.  
These models provide scientists with the ability to control for multiple variables that 
cannot be controlled for in human subjects, such as initial age of drug exposure, dosage, 
and duration of drug exposure.  Although there are many limitations in the extrapolation 
from animal models to human addiction, the use of animal models provides valuable 
information and there are a variety of paradigms that have been developed in animals for 
assessing drug use (Tzschentke, 2007).  Furthermore, animal models have allowed for 
invasive and in-depth exploration of the mechanisms underlying adolescent drug use, 
including the important brain regions that might be involved. Therefore, the goal of the 
present research is to evaluate the influence of social environment on morphine 
sensitivity in adolescent mice. Specifically, I sought to learn more about the influences 
of social environment on the development of morphine reward and dependence, as well 
as the effects of social housing conditions on the antinociceptive properties of opioids.  
Moreover, I explored the underlying molecular mechanisms for these effects.  
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CHAPTER II 
GENERAL METHODS 
 
2.1 Subjects 
 Adolescent C57BL/6 male mice were used for the experiments. Mice were 
purchased from Envigo (Houston, TX), or bred in-house (Chapter VI), and acclimated to 
the colony for a minimum of 5 days before the start of experiments. They received food 
and water ad libitum and were housed on a 12:00 hour light/dark cycle with the lights on 
at 7:30am and off at 7:30pm. All procedures were conducted in accordance with the 
National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals 
after receiving the approval of Texas A&M University’s Institutional Animal Care and 
Use Committee. 
 
2.2 Housing Conditions 
 All mice were group-housed, 4 per cage. As depicted in Figure 1, mice were 
housed in one of 3 housing conditions: morphine only, mixed, and saline only 
conditions. In morphine only cages, all mice received repeated treatments with 
morphine, while in saline only cages, all mice received repeated treatments with saline.  
However, in mixed cages, half of the animals received saline (referred to as saline cage-
mates) and half received morphine (referred to as morphine cage-mates). 
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Figure 1. Schematic of social housing conditions. 
 
 
2.3 Drugs 
Morphine sulfate and sodium pentobarbital (10 ml/kg) were purchased from 
Sigma-Aldrich (St. Louis, MO). The doses represent salt concentrations. For experiment 
4, clozapine-N-oxide was purchased from Sigma-Aldrich, as well.  
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CHAPTER III 
EXPERIMENT 1: EFFECT OF SOCIAL ENVIRONMENT ON THE ACQUISITION 
AND EXTINCTION OF MORPHINE CONDITIONED PLACE PREFERENCE IN 
ADOLESCENT MICE* 
 
3.1 Introduction 
 As discussed in Chapter 1, an issue that many adolescent opioid addicts report is 
a lack of social support, which includes feeling a lack of social attachment. Similarly, in 
rodents, a lack of social interaction is aversive.  In a series of experiments, Panksepp and 
coworkers showed that a withdrawal syndrome induced by social isolation produces 
symptoms similar to opioid withdrawal (Panksepp, 1980).  Panksepp and colleagues 
(1978) examined whether opioids could alleviate social distress, defined as a brief period 
of social isolation, in young puppies. Indeed, opioid treatment alleviates social distress in 
a variety of animal species including chicks and guinea pigs (Panksepp, Herman, et al., 
1978; Panksepp, Vilberg, et al., 1978).  This is contrasted by the fact that social play is 
rewarding, and activates reward processes in the striatum (van Kerkhof et al., 2013). 
Similarly, social affiliation and interaction can be rewarding as a social partner is 
sufficient to produce CPP, with the most robust socially-induced CPP being shown by 
adolescent males (Douglas, Varlinskaya, & Spear, 2004; Thiel, Okun, & Neisewander, 
                                                 
*Reprinted from Drug and Alcohol Dependence, 142, M.L. Shawn Bates, Michael A. 
Emery, Paul J. Wellman & Shoshana Eitan, Social housing conditions influence 
morphine dependence and the extinction of morphine place preference in adolescent 
mice, 283-289, Copyright (2014), with permission from Elsevier. 
 11 
 
2008).   Moreover, social interaction decreases levels of phosphorylated p38, a member 
of mitogen-activated protein kinase family that has been shown to be activated by drugs 
of abuse and during moderate levels of stress (Salti et al., 2015). 
Data from my lab shows that being housed with drug-naïve animals seems to 
have a protective effect on future morphine reward in adolescent males.  Specifically, 
morphine only adolescents develop a markedly higher degree of locomotor sensitization 
as compared to morphine cage-mates  (Hofford et al., 2012).  Sensitization is an indirect 
measure of drug reinforcement, and is often used as an initial assessment.  However, a 
more direct measure, conditioned place preference, or CPP, corroborates these findings. 
Cole et al. (2013) studied how social environment affects the sensitization of morphine 
reward using CPP.  In these experiments, a short CPP paradigm was used in order to 
explore the differences in the acquisition of morphine reward between morphine only 
and morphine cage-mate adolescent mice. Animals previously exposed to morphine in 
their home cages acquire morphine CPP more readily than drug-naïve animals (Gaiardi 
et al., 1991; Shippenberg, Heidbreder, & Lefevour, 1996).  Using a similar paradigm, 
my lab found that morphine-treated mice housed only with other morphine-treated mice 
(morphine only) acquired CPP after only one conditioning session. That was established 
across a variety of doses (10, 20, & 40 mg/kg). In contrast, morphine-treated mice that 
were housed with drug-naïve ones (morphine cage-mates) acquired a significantly 
lessened degree of reward after a single conditioning session.   
 The CPP acquisition paradigm is not very quantitative, and a common method to 
establish a more quantitative measure of the difference in reward acquisition is to study 
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the rate of CPP extinction.  The rate of extinction refers to the length of time required in 
order to attenuate the conditioned place preference (Kaplan & Coyle, 1998; X. Ma, 
Zhang, & Yu, 2012; Self & Choi, 2004).  In other words, if a drug-related memory is 
more established, it should take more time to extinguish it. Extinction is a process in 
which a conditioned response gradually diminishes over time as an animal learns to 
uncouple a response from a stimulus (Peters, Kalivas, & Quirk, 2009; Quirk & Mueller, 
2008). It is believed that it leads to the formation of a new, inhibitory memory that 
becomes expressed instead of the previous memory (Gantt, 1927; X. Ma et al., 2012). In 
terms of CPP, the memory of the morphine reward is the stimulus that motivates animals 
to seek out the morphine-paired chamber (Bardo, Miller, & Neisewander, 1984; Blander 
et al., 1984; Mucha & Iversen, 1984; Mucha et al., 1982; van der Kooy et al., 1982). 
Therefore, animals with memories that are less robust will most likely extinguish an 
acquired place preference more quickly than those with a strong memory. In order to 
extend the findings of Cole et al. (2013), in this experiment, I examined whether social 
environment affects the acquisition and extinction of morphine place preference using a 
longer, classical, CPP paradigm. 
 
3.2 Method 
3.2.1 Animals 
Adolescent, male mice were used in this experiment. There were 32-40 animals 
per group. Only morphine cage mate and morphine only animals were studied. The 
saline cage-mates of the morphine-treated animals remained in their home cages, and 
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treated with saline, for the entire duration of the study. Saline only and saline cage-mate 
animals were not studied for the acquisition and extinction of morphine CPP, because 
the acquisition of CPP requires multiple administrations of morphine, and this by default 
would eliminate them from being a saline only or saline cage mate conditions. 
 
3.2.2 Pretreatment Regimen 
 Mice were pretreated once daily with saline or 20 mg/kg morphine (10 mg/mL, 
s.c.) at 9:00AM for six days.  This dose represents the salt concentration. 
 
3.2.3 Conditioned Place Preference Apparatus 
 Morphine CPP was assessed in eight apparatuses.  Each apparatus contained 
three 20x20x30.5 cm square chambers.  Two of the chambers were used for 
conditioning, and contained distinct olfactory and visual (cow/lemon vs. 
checker/almond) cues, and the third chamber was neutral (containing no distinct cues).  
The olfactory scents (200µl) were applied to filter paper that was placed in the top 
corner of each chamber 5 minutes before the beginning of the session.   
 These apparatuses were located inside a Photobeam Activity System (San Diego 
Instruments, San Diego, CA), which allowed for the automated assessment of time spent 
in each chamber, as well as location throughout test sessions.  The system was located in 
a soundproof room with dim light, and a continuously operating 40 dB white noise 
generator. 
 14 
 
 On habituation, test, and extinction sessions, mice were placed in the neutral 
chamber and allowed free access to all three chambers, while on conditioning days, they 
were confined to one of the chambers. Mice were habituated to the test room for 30 
minutes prior to being individually placed in an apparatus, which was thoroughly 
cleaned with 70% ethanol and water, and completely dried between sessions. 
 
3.2.4 Morphine CPP Experimental Design 
 Three days following the final dose of morphine pretreatment, CPP acquisition 
began.  This involved a “biased” CPP design (Tzschentke, 2007).  During habituation, 
mice were placed in the neutral chamber of the CPP apparatus, and allowed to explore 
the apparatus in its entirety for 30 minutes. This provided the baseline preference, which 
was used to determine subsequent conditioning chambers.  Conditioning began the day 
after habituation, and lasted for 4 or 8 days, for 60 minutes each day.  Animals were 
injected with saline (10 ml/kg, s.c.), and confined to the initially preferred compartment 
in the morning (9:00AM), and injected with morphine (5 mg/kg) and confined to their 
initially non-preferred compartment, in the afternoon (2:00 PM).  After the first 4 days 
of conditioning, animals underwent a test session, which was identical to the habituation 
session.  If place preference was not learned, defined as a significant increase in time 
spent in the morphine-paired chamber, animals underwent another 4 days of 
conditioning that were identical to the first 4.  
 Extinction sessions began the day after the last acquisition test. Animals that 
developed place preference were given once daily extinction sessions until they achieved 
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extinction. These sessions were similar to the habituation and test sessions. The animals 
were considered to have reached extinction when they displayed three consecutive days 
of no preference for the morphine-paired chamber. 
 
3.2.5 Statistical Analysis 
 Conditioned place preference was determined as the difference in the time spent 
in the morphine-paired chamber and the time spent in the saline-paired chamber. In other 
words, a difference score was calculated between how long the animal was in the 
morphine-paired chamber on test day, and how much time it spent in the saline-paired 
chamber on test day. Differences in preference were analyzed using a split-plot ANOVA 
with a between-group factor of housing and a within-group factor of time.  Extinction 
criterion was defined as the first days of 3 consecutive days in which a mouse did not 
display preference for the morphine-paired chamber.  Survival scores for the number of 
mice per treatment condition that met criterion using the Kaplan-Meier survival 
estimation were computed.  Differences between the experimental groups were analyzed 
using the Breslow (Generalized Wilcoxon) test. Differences with p-values of less than 
0.05 were considered statistically significant. 
 
3.3 Results 
3.3.1 Social housing conditions’ effect on acquisition of morphine CPP 
 On habituation day, both morphine only (-7.14 ± 1.8s) and morphine cage-mate 
(-9.25 ± 1.4s) mice prefer the saline-paired chamber, and there were no significant 
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differences between the experimental groups (t(70) = -0.90, NS). Morphine only animals 
acquired CPP faster than morphine cage-mates (Breslow Generalized Wilcoxon: χ2 (1) = 
7.33, p<0.01). All 32 morphine only animals acquired CPP after 4 conditioning sessions. 
For the morphine cage-mates, 19 of the animals acquired morphine CPP after 4 
conditioning sessions and 21 acquired CPP after 8 conditioning sessions. This is 
consistent with previous studies from the lab, which showed that CPP was acquired 
more quickly by morphine only animals. Twelve morphine only animals (27.3%) and 16 
morphine cage-mate animals (28.6%) did not acquire CPP and were omitted from the 
study. Although rate of acquisition differed, morphine cage-mate (340.18 ± 34.3) and 
morphine only (346.99 ± 37.8) mice show comparable levels of CPP acquisition during 
the conditioning phase of the experiment (t(70) = -0.13, NS). Moreover, comparable 
levels of CPP were observed in morphine cage-mates who acquired after 4 (369.68 ± 
53.6) and 8 (313.50 ± 44.2) conditioning trials (t(38) = -0.81, NS). 
 
3.3.2 Social housing conditions’ effect on morphine CPP extinction 
 All morphine cage-mate animals were subjected to 30 minutes daily extinction 
sessions. For the morphine only mice, 15 of them were subjected to 30 min extinction 
sessions and 17 of them were subjected to 60 min extinction sessions. After 40 days of 
daily 30-minute extinction sessions, I did not observe a significant change in the overall 
preference scores for the morphine-paired chamber in the morphine-only group (Figure 
2), and only 40% of these animals reached extinction criteria (Figure 3). However, 
morphine only animals were able to extinguish their CPP after using a more robust 
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extinction procedure.  When 60-minute extinction sessions were applied, 64.7% of the 
morphine only animals did reach extinction criteria (Figure 3), and exhibited an overall 
loss in the preference for the morphine-paired chamber. 
 In stark contrast with the morphine only group, morphine cage-mate animals 
readily extinguished their CPP for the morphine-paired chamber when exposed to 30-
minute daily extinction sessions.  Using a repeated-measures ANOVA, I found 
significant differences between morphine only and morphine cage-mates in their CPP 
extinction. There was a main effect of housing (F(1, 56) = 5.27, p< 0.05) and time (F(39, 
2067) = 1.825, p < 0.001), and a significant interaction between time and housing (order 
5: F(1,56) = 4.05, order 33: F(1, 56) = 5.823, p < 0.05).  Moreover, 72.5% of the 
morphine cage-mates extinguished CPP during the 40 days of 30-minute extinction 
sessions (Figure 3).  A Kaplan-Meier survival analysis showed that morphine only mice 
reached extinction criteria significantly slower than morphine cage-mates when both had 
30-minute daily extinction sessions (Breslow (Generalized Wilcoxon): χ2(1) = 8.46, p< 
0.01).  There were no significant differences in the extinction rate between morphine 
cage-mates that acquired CPP after 4 or 8 conditioning sessions (χ2(1) = 0.51, NS).  
Interestingly, morphine only animals extinguished morphine CPP more slowly than both 
of the morphine cage-mate groups: animals that acquired after 4 (χ2(1) = 11.49, 
p<0.001) or 8 (χ2(1) = 4.62, p<0.05) sessions. 
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Figure 2.  The mean preference for the morphine-paired chamber. Morphine cage-mates 
(black line) subjected to 30 min daily extinction procedure and in the morphine only 
groups subjected to 30 min (gray line) or 60 min (dotted gray line) daily extinction 
sessions. Results are presented as mean ± SEM. 
Figure 3. The number of animals to achieve extinction criteria over the 39 days of 
extinction procedure in the morphine cage mates (black line) subjected to 30 min daily 
extinction procedure and in the morphine only groups subjected to 30 min (gray line) or 
60 min (dotted gray line) daily extinction sessions. 
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3.4 Discussion 
Extinction of a drug-paired memory is essentially extinction of the association 
between the interoceptive sensation caused by the drug and the external cues associated 
with it. It has previously been shown that prior administration of morphine leads to 
sensitization of its rewarding properties (Gaiardi et al., 1991; Lett, 1989; Shippenberg et 
al., 1996). Sensitization involves an increase in a specific drug effect following repeated 
use. Thus, an animal previously administered morphine is expected to be sensitized to 
morphine, and this would lead to a longer time to extinguish a morphine place 
preference. In my experiments, the morphine only animals extinguish morphine place 
preference much more slowly than morphine cage-mates. This suggests that the 
morphine cage-mates are less sensitized to the rewarding properties of morphine as 
compared to the morphine only mice. Thus, the present study extends and supports my 
previous study demonstrating the ability of social housing conditions to modulate the 
rewarding properties of morphine in adolescent mice. Specifically, my previous study 
demonstrated that exposure to drug-naïve animals slows the acquisition rate of morphine 
CPP (Cole et al., 2013). 
I detected fluctuations in place preference across days in some of the animals 
tested. These fluctuations are likely due to the fact that extinction testing lasted for a 
long period of time, and some animals may have experienced a spontaneous recovery of 
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their place preference. Spontaneous recovery is a phenomenon in classical, Pavlovian 
conditioning paradigms in which an extinguished response may resurface (Rescorla, 
2004). Spontaneous recovery can occur for multiple conditioning paradigms, and has 
been shown to occur in cocaine seeking (Di Ciano & Everitt, 2004; Peters, LaLumiere, 
& Kalivas, 2008) and for morphine place preference (X. Ma et al., 2012; Sakoori & 
Murphy, 2005).  It is possible that the lack of overall change in the mean preference to 
the morphine-paired chamber in the morphine only group is, at least partially, explained 
by spontaneous recovery. This will suggest lower rates of spontaneous recovery in the 
morphine cage-mates, in which overall change in the mean preference to the morphine-
paired chamber was observed. However, I did not experimentally test this. Further 
manipulations should be done in the future to determine if spontaneous recovery does 
occur in my place preference paradigm, and to see if differences would exist among 
housing conditions. Alternatively, the lack of change in overall mean morphine 
preference in the morphine only animals might be due to strengthening of the preference 
to the morphine-paired chamber in some of the animals that did not extinguish. This may 
also explain the increase in variance in the groups across days.  Nevertheless, morphine 
only animals did extinguish after longer extinction sessions. 
Importantly, animals remaining drug-naïve for the entire duration of the study 
(i.e. mice that were never injected with morphine, only saline, even in the CPP 
apparatus) obviously could not acquire morphine CPP, and thus, could not be tested for 
extinction. Moreover, CPP itself (i.e., administration of morphine during CPP 
acquisition) will unavoidably transform any drug-naïve cage into a cage that corresponds 
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to one of my morphine social housing conditions. For similar reasons, the saline-injected 
animals housed with the morphine cage-mates remained both undisturbed in their home 
cages and were drug-naïve for the entire duration of the study. Thus, social housing 
conditions were not changed by CPP testing, and the drug-naïve mice continue to 
provide the social housing conditions for their morphine cage-mates for the duration of 
the study. 
The results of this experiment demonstrate that social housing conditions can 
affect the extinction of morphine CPP. Because CPP extinction is related to drug craving 
and the strength of the memory of morphine reward, the present results also indicate that 
the memory of morphine reward is stronger in the morphine only animals, as compared 
to the morphine cage-mates. Nevertheless, I have only examined reward using social 
housing conditions.  However, the dependence and withdrawal symptoms caused by 
opioids are a major issue that keeps addicts from abstaining.  Therefore, in the following 
experiment, I examined the occurrence of spontaneous withdrawal symptoms, and if 
social environment affected them. 
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CHAPTER IV 
EXPERIMENT 2: EFFECT OF SOCIAL ENVIRONMENT ON MORPHINE 
DEPENDENCE IN ADOLESCENT MICE* 
 
4.1 Introduction 
In the context of human addiction, drug withdrawal refers to the noxious 
symptoms that occur after addicts attempt to abstain from using. It has been suggested 
that many people maintain drug use because of the drug’s rewarding properties, or to 
avoid withdrawal (Koob, 1992a; Koob, Wall, et al., 1989). Koob and colleagues argue 
that addiction involves the transition from an impulsive to a compulsive state.  In other 
words, while initial use of a drug is due to its positive reinforcing properties, addiction 
arises because of the onset of negative reinforcement.  Indeed, both non-medical and 
medical users of opioids often report the reasons for continued use is in order to stave off 
withdrawal symptoms (Weiss et al., 2014). Therefore, preventing withdrawal symptoms 
was considered to be more important for continued use than pain relief (in medical 
users). Moreover, as previously stated, social support may help to ameliorate withdrawal 
(Harocopos, Allen, & Paone, 2016).  
Withdrawal symptoms are also present in animal models.  The occurrences of 
these symptoms that arise following the cessation of drug administration serve as an 
                                                 
*Reprinted from Drug and Alcohol Dependence, 142, M.L. Shawn Bates, Michael A. 
Emery, Paul J. Wellman & Shoshana Eitan, Social housing conditions influence 
morphine dependence and the extinction of morphine place preference in adolescent 
mice, 283-289, Copyright (2014), with permission from Elsevier. 
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indicator for dependence and addiction. Typically, withdrawal occurs upon cessation of 
chronic use of a drug, although some substances like alcohol, may induce withdrawal 
after single use, or can occur even during use. Withdrawal states in rodents present as a 
variety of symptoms.  Repetitive jumping, or escape attempts, during withdrawal is 
correlated with dependence, as drug-naïve animals do not jump spontaneously, when 
placed in a “confined” space (Schulz & Herz, 1977).  Withdrawal from several 
substances also activates the HPA axis, and produces elevated corticosterone levels, and
gene expression of CRF in the nucleus accumbens (Brown & Russell, 2004; Collier, 
1980; Hyman, 1993; Koob, 1992a; Malin et al., 1992; Manik & Katz, 1984).  
Withdrawal has also been shown to modulate affective states in the rodent, and produce 
increases in anxiety and depression-associated behaviors including anhedonia, or 
decreased pleasure from a previously natural reward, and increased aggression.   
In rodent models, social environment has been reported to modulate withdrawal. 
Adolescent and adult rats that were housed in isolation for 30 days showed fewer 
withdrawal symptoms than those that were pair-housed (Broseta et al., 2005; Coudereau 
et al., 1997). Data from my lab show that social conditions can affect plasma 
testosterone levels, as saline-treated animals housed with morphine-treated ones (i.e., 
saline cage-mates) showed decreased testosterone as compared to saline only mice 
(Hofford, Wellman, & Eitan, 2011).  Opioids have been shown to modulate testosterone 
levels, as opioid treatment produces androgen-deficiency syndrome (O'Rourke & 
Wosnitzer, 2016).  Nevertheless, the saline cage-mates were not administered morphine, 
which suggests that their testosterone levels were affected by the morphine-treatment 
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animals in their social environment. Lastly, social stress was shown to produce a state of 
opioid dependence, thus further supporting a role for social environment on opioid 
withdrawal (Chaijale et al., 2013). 
 Because opioid withdrawal is a major issue, and because social environment has 
been shown to affect it, I monitored withdrawal symptoms in this experiment. Because 
previous data in my lab suggests that morphine may produce more severe behavioral 
alterations in morphine only animals as compared to all other groups, I hypothesized that 
morphine only animals would display more repetitive jumping during withdrawal than 
any of the other groups.  
 
4.2 Methods 
4.2.1 Subjects 
Adolescent, male mice were used in this experiment. There were 32-40 animals 
per group as outlined above. 
 
4.2.2 Pretreatment Regimen 
Mice were treated once daily for six days with saline or 20 mg/kg morphine (10 mg/mL, 
s.c.) at 9:00AM. This dose represents the salt concentration. 
 
4.2.3 Spontaneous Withdrawal Symptoms 
Withdrawal symptoms were tested 4, 8, 24, and 48 hours following the final 
morphine injection. They were individually placed in Plexiglas cylinders (37 cm tall x 
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14.5 cm in diameter) and videotaped for 30 minutes. The videotapes were then scored 
for jumping behavior by observers who were blind to treatment. 
 
4.2.4 Statistical Analysis 
 The differences in number of jumps between the morphine cage-mates and 
morphine only animals were analyzed using a split-plot ANOVA (SPSS Statistics 18, 
Somers, NY) with a between-group factor of housing and a within-group factor of time 
(4, 8, 24, and 48 hours). Post hoc contrasts between each treatment group were 
conducted using Bonferroni post hoc procedure. 
 
4.3 Results 
 The number of jumps at 4, 8, 24, and 48 hours following the final morphine 
administration were assessed, and are presented in Figure 4. Using a split-plot ANOVA, 
I found a main effect of housing (F(1, 94) = 4.17, p < 0.05), a main effect of time (F(3, 
282) = 15.27, p < 0.0001), and a significant interaction between housing and time (F(3, 
282) = 2.93, p < 0.05). A Bonferroni post-hoc analysis showed that morphine cage-
mates jumped significantly less than morphine only animals at the 24-hour time point 
(p<0.05). 
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Figure 4. The number of jumps in the morphine cage-mates (black bars) and morphine 
only (gray bars) animals 4, 8, 24, and 48 h after the last administration of morphine in 
their home cages. *Indicates significant difference (p < 0.05) from morphine only 
animals. Results are presented as mean ± SEM. 
 
 
 
4.4 Discussion 
Social housing conditions affected somatic withdrawal symptoms. Morphine 
only animals exhibited significantly more jumping than the morphine cage-mates. 
Repetitive jumping during opioid withdrawal is correlated with opioid dependence, as 
the literature (Schulz & Herz, 1977) and my previous studies using identical testing 
conditions (Hodgson et al., 2008) demonstrate that drug-naïve animals do not jump 
spontaneously when placed in a “confined” space. In fact, there are a variety of somatic 
withdrawal symptoms that may be displayed by a mouse, including wet dog shakes, paw 
tremors, and teeth chattering, but jumping is the most pronounced of these symptoms 
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(Stevens & Klemm, 1979). Different patterns of social interaction, such as increased 
aggression, as measured by increases in threat and attack behaviors towards 
conspecifics, may also occur during periods of opioid withdrawal (Kantak & Miczek, 
1986, 1988). Given that this study examined the withdrawal syndrome in a spontaneous 
(non-induced) model, following once daily administration of 20 mg/kg morphine, I did 
not observe a significant amount of wet dog shakes, paw tremors, and teeth chattering. 
Future studies, using higher doses of morphine, or a naloxone-precipitated model, should 
examine the effects of social housing on the display of other withdrawal syndromes.  
The social housing conditions tested in this study might modulate morphine 
dependence and reward because of differences in the quality of social interaction 
between the morphine-treated animals and between the drug-naïve animals and their 
morphine cage-mates. Endogenous opioids play an important role in social play and 
social reward (Panksepp et al., 1980; Trezza, Baarendse, & Vanderschuren, 2010). 
Morphine decreases social investigation in mice (Kennedy et al., 2011; Landauer & 
Balster, 1982), and opioid withdrawal increases social aggression (Kantak & Miczek, 
1986, 1988). Thus, it may be that morphine-treated animals are less engaged with their 
cage-mates and are more aggressive with one another during withdrawal. This might 
resemble a form of social inaccessibility existing in a non-supportive environment. 
Animals that are socially isolated are more prone to develop drug dependence and to 
display signs of drug reward and drug seeking (Bowling & Bardo, 1994; El Rawas et al., 
2009; Starosciak et al., 2012; Zakharova et al., 2009). In contrast, the drug-naïve animals 
might provide constant tactile feedback (Vrontou et al., 2013), or some other form of 
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beneficial interaction, to their morphine cage-mates. This would result in the morphine 
cage-mates living in a housing condition that resembles a more supportive environment.  
Supportive social interactions were demonstrated to play a role in cessation of 
opioid use in human adolescents (Hyucksun Shin, 2012; Vaughn et al., 2012). Moreover, 
animals that are housed in enriched environments demonstrate attenuated reward to 
drugs of abuse including heroin, ecstasy, and methamphetamine (El Rawas et al., 2009; 
Starosciak et al., 2012; Zakharova et al., 2009). It is possible that the housing conditions 
in which the morphine cage-mates live in represent an environment that is more socially 
enriched as compared to the housing conditions of the morphine only mice.  
The previous experiments focus on morphine reward and dependence.  One 
factor that contributes to the possibility of developing addiction is the chronic use of 
morphine to treat pain.  Therefore, the following experiment examines whether or not 
the paradoxical pain symptoms that are concomitant with morphine use, and morphine 
analgesia, might be affected by social environment. 
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CHAPTER V 
EXPERIMENT 3: EFFECT OF SOCIAL ENVIRONMENT ON THE 
ANTINOCICEPTIVE PROPERTIES OF MORPHINE * 
 
5.1 Introduction 
 Opioids are commonly prescribed for treating moderate-to-severe pain, and their 
popularity is related to their potent analgesic properties (Furlan et al., 2006; Kalso et al., 
2004; Volkow et al., 2011).The ability of opioids to produce pain relief (analgesia or 
antinociception) has been well-documented. However, chronic opioid use, both 
recreationally and under physician supervision, is complicated by the development of 
antinociceptive tolerance and opioid-induced hyperalgesia (Angst & Clark, 2006; L. 
Chen, Sein, et al., 2014; Jamison & Mao, 2015; Mao, 2002).   
Antinociceptive tolerance refers to desensitization of antinociceptive 
mechanisms, which usually requires dose escalation to achieve the original response. 
Opioid-induced hyperalgesia refers to abnormal pain sensitivity induced by opioids due 
to sensitization of nociceptive mechanisms. This abnormal pain sensitivity refers both to 
increased sensitivity to noxious stimuli (termed hyperalgesia), and to an increased 
painful response to previously non-noxious stimuli (termed allodynia). Heroin addicts 
describe sensations of hyperalgesia after chronic use (Carcoba et al., 2011).  Moreover, 
                                                 
* Reprinted from European Journal of Pain, 20, M.L. Shawn Bates, Michael A. Emery, 
Paul J. Wellman & Shoshana Eitan, Social environment alters opioid-induced 
hyperalgesia and antinociceptive tolerance in adolescent mice, 998-1009, Copyright 
(2016), with permission from Wiley. 
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patients on methadone maintenance therapy display hyperalgesic responses to cold-
pressor pain (Compton, Charuvastra, & Ling, 2001). These adverse effects may also 
undermine the expected outcomes of opioid treatment. Moreover, clinical data have 
shown that hyperalgesia and allodynia may lead to other adverse outcomes, including 
negative mood states, such as depression, anger, and confusion (White, 2004).  
Therefore, developing a treatment that may combat these effects is of importance.  
Rodent models have been used to examine opioid analgesia, and social 
enrichment has been shown to affect it.  For example, rats housed in social isolation 
appear to be less sensitive to the antinociceptive effects of morphine in the tail shock, 
tail compression, and tail withdrawal tests (Kostowski et al., 1977; Panksepp, 1980; M. 
A. Smith et al., 2005). Interestingly, isolated mice exposed to opioids with lower 
efficacy for the µ opioid receptor, including buprenorphine, butorphal, and nalbuphine, 
showed diminished antinociception of these drugs (M. A. Smith et al., 2005).  Also, 
when combined with morphine (an opiate with high µ opioid receptor efficacy), these 
drugs antagonized antinociceptive effects in isolated animals, but potentiated them in 
socially housed animals. 
The experience of pain appears to be modulated by social environment (for 
review see (Morales-Rivera et al., 2014)). Social play deprivation and peer-rejection 
during adolescence decreased pain reactivity in rodents (P. Schneider, Hannusch, et al., 
2014). Moreover, opioid antinociception is affected by social stress (Huhman et al., 
1991; Miczek, Thompson, & Shuster, 1982; Rodgers & Hendrie, 1983). Additionally, 
the observation of a cage-mate in pain or the observation of a cage-mate who does not 
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experience pain increases or reduces, respectively, the responses to pain in their pain-
inflicted cage-mates (Langford et al., 2006). Specifically, mice that were tested in groups 
of two, that were both treated with acetic acid, displayed greater pain sensitivity than 
mice that were tested in isolation, or when only one of the mice received acetic acid. 
Lastly, it was shown that being housed with alcohol-withdrawn animals increases pain 
sensitivity in alcohol-naïve ones (M. L. Smith et al., 2016).  This suggests that pain 
mechanisms can be modified by social environment. 
The previous studies focus on susceptibility to develop opioid dependence and 
reward in adolescents and whether or not it is dependent on the nature of social housing 
conditions. Given that social environment alters both opioid-induced behaviors and 
nociceptive mechanisms, in this study I examined the effect of social housing conditions 
on the development of both antinociceptive tolerance and opioid-induced hyperalgesia in 
adolescent mice.  I hypothesized that morphine only animals would show elevated signs 
of antinociceptive tolerance and hyperalgesia, as compared to morphine cage-mates. 
 
5.2 Methods 
5.2.1 Animals 
 Adolescent, male mice were used in this experiment. There were 16-20 animals 
per group. 
 
 
 
 32 
 
5.2.2 Pretreatment regimen 
 Mice were injected once daily (9:00AM) in their home cage for 6 consecutive 
days (experiment 1, tail withdrawal) or 14 consecutive days (experiment 2, allodynia and 
hyperalgesia) with 20 mg/kg of morphine or 0.9% saline (10 ml/kg). This dose 
represents the salt concentration. 
 
5.2.3 Experiment 1 - Tail withdrawal 
 Morphine’s ability to relieve pain was measured with the tail withdrawal assay. 
Animals were gently restrained and placed in a plastic conical tube, and had the distal 
half of their tail set in a 48oC water bath. The length of time to withdraw the tail was 
recorded in seconds. Tail withdrawal was defined as a strong flexion of the entire tail 
from the water. Lastly, a maximum cutoff time of 60 seconds was set to prevent tail 
tissue damage. 
 The first portion of the experiment included a habituation session, followed by a 
baseline session 15 minutes later.  Fifteen minutes after the baseline session, all mice 
were injected with morphine (10 mg/kg, 10 mL/kg).  The latency to withdraw the tail 
was recorded 30 minutes following injection, and every subsequent 30 minutes 
thereafter for 5 hours.  Between time points, mice were returned to their home cages.  
Animals were tested 24 hours following the final treatment, and then again at 7, 14, 21, 
and 28 days.  For each time point, percent maximum possible effect (%MPE) was 
calculated using this formula:  
(
[withdrawal latency]-[baseline latency]
[60s]-[baseline latency]
)  ×100 
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5.2.4 Experiment 2- Allodynia and Hyperalgesia 
5.2.4.1 Mechanical allodynia 
Mechanical allodynia was assessed using nylon von Frey filaments.  Mice were 
placed in a Plexiglas cylinder on top of a mesh platform. The filaments were applied to 
the plantar surface of the hind paw – of both feet – until a withdrawal response was 
provoked.  If no response is given, the next stiffer fiber was applied to the same paw 
until it evoked a response.  However, if there was a response, a less stiffer fiber was 
applied until there was no longer a response.  The final filament to produce a response 
was recorded, and scores were averaged across both feet. 
5.2.4.2 Cold allodynia 
Cold allodynia was assessed by applying acetone to the plantar surface of the 
hind paw of both feet. Mice were placed atop a mesh platform and once the animal 
withdrew its paw, the severity of response was recorded, and scores were averaged 
across both feet. I used a 4-point scale, which is depicted below: 
Table 1. Scale for scoring of cold allodynia 
Score Type of Response 
1 Slow, smooth paw withdrawal response 
2 Rapid paw withdrawal response 
3 Rapid paw withdrawal response; with flick 
4 Rapid paw withdrawal response; with vocalization or licking 
 34 
 
5.2.4.3 Hyperalgesia 
 The hot-plate test was utilized to assess analgesia.  The temperature was 
maintained at 55° ± 1°C, and mice were put inside a Plexiglas cylinder on top of the 
plate.  Licking of a hindpaw, or jumping out of the cylinder, was recorded as a response 
– latency to provoke one of these responses was recorded in seconds.  Lastly, similar to 
the tail withdrawal assay, a latency time of 60 seconds was set to prevent tissue damage 
each trial. 
  
5.2.4.4 Experimental Design 
Animals were tested the day before morphine treatment began in order to 
establish baseline scores (PND 25).  Testing order was as follows: mechanical allodynia 
→ cold allodynia → hot-plate test. The next day, morphine treatment began (experiment 
day 1). Mice were tested again on experimental days 7, 14, 21, and 28. On each test day, 
they were given a pretest, injected with morphine (10 mg/kg, s.c.), and then given a 
posttest one hour later.  Percent maximum possible effect was calculated as described in 
the tail withdrawal assay.  Lastly, the development of hyperalgesia was calculated by 
computing the difference scores for the daily pretests and the baseline scores (on 
experimental day 0). Drug potency was calculated by computing the differences scores 
between the posttest and pretest scores.  
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5.2.5 Statistical Analysis 
5.2.5.1 Tail withdrawal 
The differences in baseline tail withdrawal latencies among the experimental 
groups on each testing day were analyzed using two-way ANOVA with between-group 
factors of treatment (morphine, saline) and housing (only, cage-mates). Then, for each 
mouse and for each time point, percent maximum possible effect (%MPE) was 
calculated using the above formula.  The differences in %MPE between the different 
experimental groups on each day of tail withdrawal testing was analyzed using a split-
plot ANOVA with between-group factors of treatment and housing and a within-group 
factor of time (every 30 min for 5 h). The differences in latencies (using log 10(x + 1) 
transformation) between the different experimental groups were analyzed similarly. Post 
hoc contrasts between each treatment group were conducted using Bonferroni procedure. 
5.2.5.2 Allodynia and hyperalgesia 
The differences between the weekly pre-treatment scores and the original 
baseline score were analyzed using a split-plot ANOVA with between-group factors of 
treatment (morphine, saline) and housing (only, cage-mates) and a within-group factor of 
time (week). Additionally, for the hot plate test, for each mouse and for each time point, 
percent maximum possible effect (%MPE) was calculated as explained above. Similar to 
the raw latencies (scores), the differences in %MPE between the different experimental 
groups were each analyzed using a split-plot ANOVA with between-group factors of 
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treatment and housing and a within-group factor of time. Post hoc contrasts between 
each treatment group were conducted using Bonferroni procedure.  
 
5.3 Results 
5.3.1 Tail withdrawal 
 No significant differences between groups in tail withdrawal latencies at baseline 
were seen.  Using a two-way ANOVA, I found no main effect of treatment (F(1,60) = 
0.52, NS), no main effect of housing (F(1,60) = 0.80, NS), and no treatment x housing 
interaction (F(1,60) = 1.38, NS). Additionally, both morphine only and morphine cage-
mate animals developed similar degrees of antinociceptive tolerance (Figure 5). 
Repeated measures ANOVA revealed a main effect of time (F(9, 540) = 126.46, p< 
0.0001), a main effect of treatment (F(1, 60) = 33.58, p< 0.0001), a significant 
interaction between time and housing (F(9,540) = 3.23, p< 0.001), and a significant 
interaction between time and treatment (F(9, 540) = 14.35, p< 0.0001). Bonferroni post 
hoc comparisons revealed a significantly reduced response to morphine in the morphine-
treated animals as compared to the saline-injected animals (Figure 5A). However, no 
significant differences were observed between morphine only animals and morphine 
cage-mates. 
 A week after discontinuation of morphine treatment, no significant differences in 
baseline tail withdrawal latencies were observed among the different experimental 
groups. Two-way ANOVA revealed no main effect of treatment (F(1,60) = 0.07, p> 
0.05, NS), no main effect of housing (F(1, 60) = 1.21, p> 0.05, NS) and no interaction 
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between treatment and housing (F(1, 60) = 0.00, p> 0.05, NS). However, a significant 
difference in the magnitude of antinociceptive tolerance was observed between 
morphine only mice and morphine cage-mates. Specifically, antinociceptive 
tolerance was still observed in the morphine only animals, but not in the morphine cage-
mates, as compared to saline-injected animals (Figure 5B). Repeated measures ANOVA 
revealed a main effect of time (F(9, 540) = 96.9, p< 0.0001), and a main effect of 
treatment (F(1, 60) = 4.53, p< 0.05), a significant interaction between time and housing 
(F(9, 540) = 2.78, p< 0.01), a significant interaction between time and treatment (F(9, 
540) = 3.71, p< 0.0001), and a significant interaction between time, housing and 
treatment (F(1, 540) = 3.20, p< 0.001). Bonferroni post hoc comparison revealed 
a significantly reduced response to morphine in the morphine only animals as compared 
to morphine cage-mates and to the saline-injected animals (Figure 5B). No significant 
differences were observed between morphine cage-mates and the saline-injected 
animals.  
Two and three weeks after discontinuation of morphine treatment, no significant 
differences in baseline tail withdrawal latencies were observed between the different 
experimental groups. Additionally, no significant differences in the response to 
morphine between the different experimental groups were observed at that time (Figures 
5C & D). Similar results were obtained when the differences in latencies (i.e. the 
differences between post- and pre-morphine latencies) were analyzed. 
 
 
 38 
 
 
Figure 5. Results from the tail withdrawal test. Mice (n = 16/group) were treated for 6 
days with morphine or saline. The differences in %maximum possible effect to withdraw 
their tails between the different experimental groups were recorded following 6 days of 
morphine or saline (A) as well as one (B) two (C) and three (D) weeks after 
discontinuation of morphine treatment. Mice were tested for withdrawal latencies at 
baseline and then every 30 min for 5 h post-morphine or saline injections. *indicates 
significant difference (p < 0.05) from saline only animals; §indicates significant 
difference (p < 0.05) from morphine cage-mate animals. SAL, saline only; SCM, saline 
cage-mates; MCM, morphine cage-mates; MOR, morphine only. Results are presented 
as mean ± SEM. 
 
 
5.3.2 Mechanical Allodynia 
Differences between weekly pre-treatment scores (in grams) and the original 
baseline score are presented in Figure 6A. Three-way ANOVA revealed a main effect of 
week (F(1, 103) =17.99, p<0.0001) and significant interactions between week and 
treatment (F(1, 103) =10.12, p<0.01). Tukey’s HSD post-hoc comparison revealed 
significantly reduced pain reactivity in morphine only mice (p<0.05) and a trend for 
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reduced pain reactivity in morphine cage mates (p=0.113) at 3 weeks after 
discontinuation of morphine treatment as compared to the saline-injected mice. 
The responses to saline (i.e., differences between post- and pre-saline scores in 
grams) are presented in Figure 6B. Three-way ANOVA revealed only a main effect of 
week (F(1, 32) =12.63, p<0.01). However, no significant differences were found among 
the different experimental groups.  
The development of antinociceptive tolerance in the different experimental 
groups (i.e., the differences between post- and pre-morphine scores in grams) is 
presented in Figure 6C. Three-way ANOVA revealed a main effect of week (F(1, 67) 
=82.13, p<0.0001), a main effect of treatment (F(1, 67) =72.59, p<0.0001), a significant 
interaction between treatment and week (F(1, 67) =29.12, p<0.0001), and a significant 
interaction between treatment and housing (F(1, 67) =12.98, p<0.001).  
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Figure 6. Results from the von Frey Filaments test. Mice (n=16-20/group) were treated 
for 14 days with morphine or saline. They were recorded weekly during morphine 
treatment and in the following 3 weeks of abstinence for: (A) the change in baseline 
scores (differences between weekly pre-treatment scores and the original baseline score 
in grams); (B) the response to saline (differences between post- and pre-saline scores in 
grams); and (C) the response to morphine (differences between post- and pre-morphine 
scores in grams). * indicates significant difference (p < 0.05) from saline only animals; § 
indicates significant difference (p < 0.05) from morphine cage-mate animals. SAL – 
Saline Only, SCM – Saline Cage-mates, MCM – Morphine Cage-mates, MOR – 
Morphine Only. Results are presented as mean ± SEM. 
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Tukey’s HSD post-hoc comparison revealed a significant development of 
antinociceptive tolerance in both the morphine cage-mates and morphine only mice 
during the 14 consecutive days of morphine treatment (p<0.001). Notably, the 
magnitude of the antinociceptive tolerance was significantly more robust in the 
morphine only animals as compared to the morphine cage-mates (p<0.05). Additionally, 
in line with the results from the tail withdrawal test, antinociceptive tolerance was more 
persistent in the morphine only animals. In the morphine cage-mates, antinociceptive 
tolerance was observed one week (p<0.0001), but not 2 weeks (p>0.05, NS), after 
discontinuation of morphine treatment. In contrast, antinociceptive tolerance was 
observed both one week (p<0.0001) and 2 weeks (p<0.01) after discontinuation of 
morphine treatment in the morphine only group. 
 
5.3.3 Cold Allodynia 
Differences between weekly pre-treatment scores and the original baseline score 
are presented in Figure 7A. A Kruskal–Wallis test revealed significant differences 
among the experimental groups after 14 days of morphine treatment (χ2=9.37, df=3, 
p<0.05), but not at other time points (7 days of morphine treatment: χ2=2.93, df=3, 
p>0.05, NS; 7 days abstinence: χ2=3.47, df=3, p>0.05, NS; 14 days abstinence: χ2=7.56, 
df=3, p>0.05, NS; 21 days abstinence: χ2=2.53, df=3, p>0.05, NS). Specifically, saline 
only animals exhibited lower pain reactivity as compared with morphine cage-mates 
(p<0.05) and morphine only (p<0.05) animals. A trend was also observed for lower pain 
reactivity in the saline only animals as compared to the saline cage mates (p=0.053). 
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Figure 7.  Results from the acetone test. Mice (n=16-20/group) were treated for 14 days 
with morphine or saline. They were recorded weekly during morphine treatment and in 
the following 3 weeks of abstinence for: (A) the change in baseline scores (differences 
between weekly pre-treatment scores and the original baseline score); (B) the response to 
saline (differences between post- and pre-saline scores); and (C) the response to morphine 
(differences between post- and pre-morphine scores). * indicates significant difference (p 
< 0.05) from saline only animals. SAL – Saline Only, SCM – Saline Cage-mates, MCM 
– Morphine Cage-mates, MOR – Morphine Only. Results are presented as mean ± SEM. 
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The responses to saline (i.e., differences between post- and pre-saline scores) are 
presented in Figure 7B. A Kruskal–Wallis test revealed no significant differences among 
the experimental groups at any time point tested (7 days of morphine treatment: χ2=1.07, 
df=3, p>0.05, NS; 14 days of morphine treatment: χ2=2.17, df=3, p>0.05, NS; 7 days 
abstinence: χ2=0.08, df=3, p>0.05, NS; 14 days abstinence: χ2=3.26, df=3, p>0.05, NS; 
21 days abstinence: χ2=0.34, df=3, p>0.05, NS).  
The development of antinociceptive tolerance in the different experimental 
groups (i.e., the differences between post- and pre-morphine scores) is presented in 
Figure7C. A Kruskal–Wallis test revealed significant differences between the 
experimental groups during the 14 consecutive days of morphine treatment (7 days of 
morphine treatment: χ2=21.87, df=3, p<0.0001; 14 days of morphine treatment: 
χ2=29.50, df=3, p<0.0001) as well as 7 days following discontinuation of treatment (7 
days abstinence: χ2=17.88, df=3, p<0.0001). However, no differences were observed 
after 14 and 21 days of abstinence (14 days abstinence: χ2=5.61, df=3, NS; 21 days 
abstinence: χ2=0.40, df=3, NS). No significant differences were observed between the 
saline only and saline cage-mate animals at any time point (NS). A significant 
development of antinociceptive tolerance was observed in both the morphine cage-mates 
and morphine only mice during the 14 consecutive days of morphine treatment as well 
as 7 days following discontinuation of morphine treatment (p<0.01). Additionally, a 
significant amount of antinociceptive tolerance was still observed in the morphine only 
animals after 14 days of abstinence (p<0.05), but not in the morphine cage-mates (NS).  
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5.3.4 Hot plate test 
The development of hyperalgesia in the different experimental groups (i.e. 
differences between weekly pre-treatment latencies and the original baseline latency) is 
presented in Figure 8A. Three-way ANOVA revealed a main effect of week (F(1, 
103)=13.20, p<0.0001) and significant interactions between week and housing 
conditions (F(1, 103) =6.54, p<0.05), week and treatment (F(1, 103) =10.49, p<0.01) as 
well as week, housing, and treatment (F(1, 103) =5.53, p<0.05). As expected, Tukey’s 
HSD post-hoc comparison revealed that hyperalgesia was not developed in the saline-
injected mice. Significant levels of hyperalgesia developed solely in the morphine only 
group following 14 consecutive days of morphine treatment (p<0.05). A trend toward a 
hyperalgesic response was already observed following 7 consecutive days of morphine 
treatment, but did not reach statistical significance (p=0.15). The opioid-induced 
hyperalgesia observed in the morphine only animals was abolished one week after 
discontinuing morphine treatment. Notably, a significant difference was observed 
between the response of the morphine cage-mates and the morphine only mice (p<0.05). 
The morphine cage-mate animals did not develop significant levels of hyperalgesia at 
any time during the 14 days of morphine treatment or after discontinuation of morphine 
treatment. There were no significant differences between the pre-treatment responses of 
the morphine cage-mates and the saline-injected mice.  
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Figure 8. Results from the hot-plate test. Mice (n=16-20/group) were treated for 14 days 
with morphine or saline. They were recorded weekly during morphine treatment and in 
the following 3 weeks of abstinence for: (A) the change in baseline latencies (differences 
between weekly pre-treatment latencies and the original baseline latency in seconds); the 
response to saline (B & C) – (B) differences between post- and pre-saline latencies in 
seconds, (C) %MPE post-saline; and the response to morphine (D & E) – (D) differences 
between post- and pre-morphine latencies in seconds, (E) %MPE post-morphine. * 
indicates significant difference (p < 0.05) from saline only animals; § indicates 
significant difference (p < 0.05) from morphine cage-mate animals. SAL – Saline Only, 
SCM – Saline Cage-mates, MCM – Morphine Cage-mates, MOR – Morphine Only. 
Results are presented as mean ± SEM. 
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The responses to saline (the differences between post- and pre-saline latencies 
and %MPE post-saline) are presented in Figures 8B and 8C. Three-way ANOVA 
revealed a main effect of week (%MPE: F(1, 32) =6.93, p<0.05; Latencies: F(1, 32) 
=7.42, p<0.01) and a significant interaction between week and treatment (%MPE: F(1, 
32) =4.20, p<0.05). However, no significant differences were observed among the 
experimental groups in their response to saline. 
The development of antinociceptive tolerance in the different experimental 
groups (i.e., the differences between post- and pre-morphine latencies and %MPE post-
morphine) is presented in Figures 8D and 8E. Three-way ANOVA revealed a main 
effect of week (%MPE: F(1, 67) =6.52, p<0.05), a main effect of housing (%MPE: F(1, 
67) =11.59, p<0.001), a main effect of treatment (%MPE: F(1, 67) = 7.32, p<0.01), and 
a significant interaction between week and treatment (%MPE: F(1, 67) =29.31, 
p<0.0001; Latencies: F(1, 67) =18.29, p<0.0001). As expected, Tukey’s HSD post-hoc 
comparison revealed that antinociceptive tolerance was developed in the morphine cage-
mates and morphine only mice (p<0.05 as compared to saline-injected mice). No 
significant differences were observed between the morphine cage-mates and morphine 
only mice at any time during the 14 days of morphine treatment or after discontinuation 
of morphine treatment. Following 14 days of morphine treatment, the antinociceptive 
tolerance in the morphine cage-mates visually appears to be stronger than in the 
morphine only mice, however not even a statistical trend was observed. Notably, 3 
weeks after discontinuation of morphine treatment, morphine produced stronger 
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antinociceptive response in the morphine only mice as compared to the saline-injected 
(p<0.05) and morphine cage-mate mice (p<0.05).  
 
5.4 Discussion 
This study demonstrated that social housing conditions modulate the adaptive 
nociceptive responses to repeated opioid treatments in adolescent male mice. 
Specifically, both mice that received morphine while being housed with drug-naïve mice 
(i.e. morphine cage-mates) and mice that received morphine while being housed only 
with other morphine-injected animals (i.e. morphine only) developed antinociceptive 
tolerance. However, the magnitude of this antinociceptive tolerance was more robust and 
persistent in the morphine only group. Additionally, morphine only animals, but not 
morphine cage-mates, developed opioid-induced hyperalgesia. Thus, this study suggests 
that certain social environments might improve the effectiveness of long-term opioid 
treatment.  
Multiple pain tests were used in this study, which differ in the modality of pain 
or type of receptors and sensory processes they examined (Berge, 2011; Le Bars, 
Gozariu, & Cadden, 2001). Notably, social housing conditions had different effects in 
the various tests. In this study, enhanced/prolonged antinociceptive tolerance was 
observed in the morphine only animals as compared to the morphine cage-mates in the 
tail withdrawal, von Frey, and acetone tests. Thus, these findings suggest that certain 
social conditions, such as housing with drug-naïve animals, can mitigate the 
development of both thermal and mechanical antinociceptive tolerance. However, no 
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differences were observed in the development of antinociceptive tolerance between 
morphine only and morphine cage mates in the hot-plate test. The contradictory findings 
might be due to the tail withdrawal response being mediated primarily by a simple spinal 
reflex, while the responses in the hot plate test involved supraspinal sensory processing 
(Dirksen et al., 1994; Piercey et al., 1981). Perhaps the development of morphine 
antinociceptive tolerance on spinal levels is more affected by social conditions than on 
supraspinal sensory processing. Alternatively, perhaps the existence of parallel 
overlapping supraspinal sensory processing involved in hot plate response as compared 
to simple spinal reflex mediating the tail withdrawal response, makes it more resilient 
for manipulations.  
Interestingly, the morphine only animals exhibit an enhanced antinociceptive 
response in the hot plate test after 21 days of abstinence as compared to the other 
experimental groups. The morphine only animals were also the only experimental group 
that experienced thermal hyperalgesia in the hot plate test. Opioid-induced hyperalgesia 
was not observed in other experimental groups or in the morphine only animals in the 
other tests. Thus, I hypothesized that the enhanced antinociceptive response might 
represent a delayed opponent process response to alter baseline pain reactivity in this 
experimental group (Leknes & Tracey, 2008; Seymour et al., 2005). Further studies are 
required to examine this phenomenon. 
The social housing conditions tested in this study might modulate opioid-induced 
tolerance and hyperalgesia because of differences in the quality of social interaction 
between the morphine-treated animals and between the drug-naïve animals and their 
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morphine cage-mates. Endogenous opioids play an important role in social play and 
social reward (Leknes & Tracey, 2008; Polakiewicz et al., 1998). Morphine decreases 
social investigation in mice (Kennedy et al., 2011; Landauer & Balster, 1982), and 
opioid withdrawal increases social aggression (Kantak & Miczek, 1986, 1988). Thus, it 
may be that morphine-treated animals are less engaged with their peers and are more 
aggressive with one another during withdrawal. This might resemble a form of social 
isolation existing in a non-supportive environment.  
Animals that are socially isolated exhibit an enhanced pain sensitivity and 
enhanced opioid antinociceptive tolerance (H. C. Becker & Baros, 2006; Coudereau et 
al., 1997; Defeudis, Defeudis, & Somoza, 1976; Puglisi-Allegra & Oliverio, 1983). In 
contrast, the drug-naïve animals that the morphine cage-mates interact with might 
provide constant tactile feedback (Vrontou et al., 2013), or some other form of beneficial 
interaction, to their morphine cage-mates. This would result in the morphine cage-mates 
living in a housing condition that resembles a more supportive environment. Thus, it is 
possible that the housing conditions in which the morphine cage-mates live represent an 
environment that is more socially enriched as compared to the housing condition of the 
morphine only mice.  
Environmental enrichment has been demonstrated to mitigate adaptive 
nociceptive responses (Berrocal et al., 2007; Rossi & Neubert, 2008; Tall, 2009; Vachon 
et al., 2013). Both the social and physical aspects of environmental enrichment were 
demonstrated to mitigate the magnitude and persistence of adaptive nociceptive 
processes (Gabriel et al., 2010). Moreover, animals that are housed in enriched 
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environments exhibit higher sensitivity to the antinociceptive properties of opioids (M. 
A. Smith, Bryant, & McClean, 2003; M. A. Smith et al., 2005). Future studies should 
further explore the nature of social interactions in the different housing conditions.  
The results of the aforementioned studies suggest that exposure to drug-naïve 
animals mitigates the development of morphine dependence and reward in adolescent 
mice (Bates et al., 2014; Cole et al., 2013). Specifically, those studies demonstrate that 
morphine only mice developed stronger dependency on morphine than did the morphine 
cage-mates. Additionally, morphine is more rewarding to the morphine only mice than 
the morphine cage-mates, as morphine cage-mates are slower in acquiring morphine 
CPP and extinguish morphine CPP more readily than do morphine only mice. Although 
the processes underlying the development of tolerance and hyperalgesia are likely 
different than the processes underlying the development of abuse, in my studies social 
housing conditions modulate both the addictive and antinociceptive properties of 
opioids. It is possible that this could be explained by the effect of social environment on 
a common mediator which affects both processes underlying the different properties of 
opioids. This might suggest that patients who exhibit more pronounced development of 
opioid-induced tolerance and/or hyperalgesia, at least in certain pain modalities, might 
be individuals who are subjected to certain social conditions which also put them at 
higher risk for developing abuse. However, additional pre-clinical and clinical studies 
are necessary to confirm this prediction. 
Opioids continue to be the most effective and commonly used drugs for 
managing moderate-to-severe pain (Volkow et al., 2011). The results suggest that certain 
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social conditions can minimize the magnitude of undesirable adaptive responses that 
develop following repeated opioid treatment. Thus, the present data represent an avenue 
that needs to be further elaborated, and could hold benefits for pain management. In the 
following experiment, I examine if social grooming – an affiliative behavior in the 
rodent – is important for conferring the protective effect observed in experiments 1-3. 
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CHAPTER VI 
EXPERIMENT 4: ROLE OF SOCIAL GROOMING AND MRGPRB4+ NEURONS IN 
THE SOCIAL HOUSING EFFECT 
 
6.1 Introduction 
 Adolescence is a stage in development with changes that are quite diverse. These 
changes may present themselves in many ways, including increases in risk-taking 
behaviors, and the possible initiation of drug use. For example, both the prefrontal cortex 
and the striatum, as well as the connection between them, have been implicated in 
adolescents’ increase in risky behaviors, including drug experimentation (Cherner et al., 
2010; DeWitt et al., 2015; Raznahan et al., 2014; Urosevic et al., 2014; Urosevic et al., 
2015). Indeed, adolescence is when most people initiate drug use, as statistics show that 
many addicts report initial drug use between the ages of 12 and 14 (National Institutes of 
Health, 2015). Moreover, abuse of opioids, including prescription pain medications, has 
increased dramatically in this population (Johnston et al., 2015), with many more 
beginning to use every day. The percent of adolescents seeking treatment for 
prescription opioids has increased from 15.5% to 34.5% in the past decade, and from 
16.6% to 25.8% for heroin dependence (Johnston et al., 2015). 
A common motif in the adolescent addict’s story is the feeling of social isolation 
and a lack of acceptance. Unfortunately, this feeling is not unfounded, as many addicts 
are shunned or ostracized because of their addiction, and report feeling low levels of 
social inclusion (Choi, DiNitto, & Marti, 2016). This lack of acceptance is particularly 
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troubling for adolescents, as social affiliation is most important during this stage of 
development. Nevertheless, the fortunate few that are able to find a social circle outside 
of other addicts report that social support can aid in the progression to abstinence 
(Johnson et al., 2016; Pagano et al., 2015).  Moreover, helping others has been shown to 
be another predictor of a greater likelihood of abstaining from drug use (Pagano et al., 
2004).   
Similar to humans, social affiliation is also rewarding in rodents. Affiliative 
interactions in rodents include social grooming and social play, which are most prevalent 
in adolescence (Spear, 2000).  Because of the importance and prevalence of social 
interaction in adolescence, it should stand that it would activate regions that underlie 
reward (Vanderschuren, Achterberg, & Trezza, 2016). Indeed, social grooming and 
social play activate portions of the classical reward circuitry in limbic and cortical 
regions (van Kerkhof et al., 2014).  Social grooming and play also lead to activation of 
the endogenous µ-opioid system, and are thought to facilitate relationships, as they are 
typically observed between related or familiar conspecifics (Nummenmaa et al., 2016; 
Vanderschuren, Niesink, et al., 1995).  Additionally, these behaviors are increased by 
administration of an opioid receptor agonist, morphine, and attenuated by an opioid 
receptor antagonist, naloxone, which further provides evidence for a role of the 
endogenous opioid system (Mitchem et al., 1999; Niesink & Van Ree, 1989).   
Although the mechanisms of the pleasurable effects of grooming have been 
established, until recently, the precise mechanism that mediated grooming was unknown.  
In an elegant set of experiments, Vrontou et al. (2013) were able to show that grooming, 
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but not a noxious stimulus like pinching, is partially mediated by peripheral dorsal root 
ganglia sensory neurons expressing Mas-related G protein–coupled receptor B4 
(MRGPRB4).  Moreover, pharmacogenetic activation of MRGPRB4+ neurons, through 
the use of Designer Receptor Exclusively Activated by Designer Drug (DREADD) 
technology, induces conditioned place preference in adolescent mice (Vrontou et al., 
2013). 
The interaction between social affiliation (in the home cage) and the propensity 
to develop drug-related behaviors in adolescent rodents has been investigated. An 
interaction was observed between social reward and sub-threshold levels of cocaine and 
nicotine (i.e. levels of the drugs that by themselves could not induced conditioned place 
preference) (Thiel et al., 2008; Thiel et al., 2009). However, group housing in home 
cages decreases cocaine CPP in adolescent rats, when levels of drug sufficient to 
establish CPP by itself were examined (Zakharova et al., 2009). Similarly, a complex 
interaction was observed between social enrichment in their home cages, social reward, 
and the establishment of morphine reward in adolescent mice (Kennedy et al., 2012). 
As demonstrated in earlier chapters, social housing conditions alter the rewarding 
properties of morphine during adolescence. Specifically, exposure to drug-naïve animals 
attenuates morphine dependence, as well as the acquisition of a conditioned place 
preference (CPP) to morphine (Bates et al., 2014; Cole et al., 2013).  Moreover, 
exposure to drug-naïve animals also expedites the extinction of morphine CPP.  Using 
DREADD technology, I examined whether activation of MRGPRB4+ neurons in 
morphine only mice (i.e., mice housed only with other morphine-treated mice) affects 
 55 
 
morphine withdrawal symptoms, and the time needed to extinguish morphine CPP.  
Conversely, I examined if, in morphine cage-mates (i.e., mice treated with morphine in 
the presence of drug-naïve animals), inactivation of these neurons produces the opposite 
effect.  Therefore, I may be able to decipher whether or not grooming, through its 
underlying physiological mechanisms, is a potential channel that mediates the social 
housing effect. 
 
6.2 Methods 
6.2.1 Animals 
All procedures were conducted in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals, and were approved by the 
Institutional Animal Care and Use Committee at Texas A&M University. Transgenic 
mice in which the entire open reading frame of the MRGPRB4 gene was replaced by an 
mtdTomato-2A-NLSCre-Frt-PGK-Neomycin-FRT cassette (i.e., transgenic mice 
carrying Cre under the control of the MRGPRB4 promotor) were purchased from 
Jackson lab (MRGPRB4-Cre mice; B6N.129S1-Mrgprb4 tm3(Cre)And/J; Bar Harbor, 
ME, USA). Mice were bred in house and housed with food and water ad lib in a 
temperature-controlled (21+/- 2°C, humidity 45%) vivarium with a 12-hour light/12-hour 
dark cycle (lights on at 7:30 AM and off at 7:30PM). 
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6.2.2 Injection of Adeno-associated viral vectors 
Following the procedure established by Anderson and colleagues (Vrontou et al., 
2013), on PND2, mice were intraperitoneally injected with Cre-dependent AAV-hSyn-
hM4D (viral vector carrying Gi-coupled receptor), Cre-dependent AAV-hSyn-hM3D 
(viral vector carrying Gq-coupled receptor), or Cre-dependent AAV-hSyn (control viral 
vector). Specifically, mice were removed from their cage and briefly placed on an ice 
bath with their heads facing up, until they appeared anesthetized (4-5 minutes).  Pups 
were then gently held, and the abdomen was cleaned with an alcohol pad. A syringe 
(insulin syringe, 0.3 cm3, 8mm length, 31G needle) was used to inject the AAV8 virus 
intraperitoneally, which was obtained from UNC Viral Vector core. The pups were then 
covered with nestlet and gently set on a heating pad until they began to move. Following 
this, they were returned to their dam, and observed to ensure that they were healthy. 
 
6.2.3 CNO and Morphine treatment regimen 
 Starting on PND 28, mice were injected twice daily (8:30AM and 6:00PM) in 
their home cage with 1 mg/kg of clozapine-N-oxide (CNO) or vehicle (intraperitoneally, 
Sigma-Aldrich, St. Louis, MO, USA). Thirty minutes after the morning injection 
(9:00AM), mice were injected for 6 consecutive days with 20 mg/kg of morphine sulfate 
(subcutaneously, Sigma-Aldrich, St. Louis, MO, USA) (Bates et al., 2014). This dose 
represents the salt concentration. The drug-naïve cage mates were injected with saline 
(10 ml/kg).  
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6.2.4 Spontaneous Withdrawal Symptoms 
 All morphine-injected animals were tested 4, 8, 24, and 48 hours following the 
final morphine injection (Bates et al., 2014). They were individually placed in Plexiglas 
cylinders (37 cm tall x 14.5 cm in diameter) and were videotaped for 30 minutes. The 
videotapes were scored for jumping behavior by observers who were blind to 
experimental group assignments. 
 
6.2.5 Conditioned Place Preference 
This involved a biased CPP design.  During habituation, mice were placed in the 
neutral chamber of the CPP apparatus, and allowed to explore the entirety of it for 30 
minutes. This provided the baseline preference, which was used to decide subsequent 
conditioning chambers.  Conditioning began the day after habituation, and lasted for 4 or 
8 days, for 60 minutes each day.  Animals were injected with saline (10 ml/kg, s.c.), and 
confined to the initially preferred compartment in the morning (9:00AM), and morphine 
(5 mg/kg), and confined to their initially non-preferred compartment, in the afternoon 
(2:00 PM).  After the first 4 days of conditioning, animals underwent a test session, 
which was identical to the habituation session.  However, unlike Chapter III, animals 
underwent another 4 days of conditioning regardless of whether or not they acquired 
place preference in the first 4 days of conditioning.  
 Extinction sessions began the day after the last acquisition test. Animals that 
developed place preference were given once daily extinction sessions until they achieved 
extinction. These sessions were similar to the habituation and test sessions. The animals 
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were considered to have reached extinction when they displayed three consecutive days 
of no preference for the morphine-paired chamber. 
 
6.2.6 Experimental Design 
 On PND2, mice were i.p. injected with one of 3 Cre-dependent Adeno-associated 
viral vectors (Cre-dependent AAV-hSyn-hM4D, Cre-dependent AAV-hSyn-hM3D, or 
Cre-dependent AAV-hSyn). On PND21, mice were weaned and housed 4 per cage 
where all animals in each cage carry the same viral vector. Starting at PND28, mice were 
injected with morphine or saline for 6 days. For the cages of mice carrying the Cre-
dependent AAV-hSyn-hM4D, 2 mice in each cage received morphine (i.e., morphine 
cage-mates) and 2 mice received saline. Of these morphine cage-mate mice, some 
received CNO (hM4D-CNO) and some received vehicle (hM4D-Veh). I also included 
control cages with mice carrying the Cre-dependent AAV-hSyn where 2 mice received 
morphine (i.e., morphine cage-mates) and 2 mice received saline. The morphine cage-
mate mice received CNO (CON-CNO). For the cages of mice carrying the Cre-
dependent AAV-hSyn-hM3D, all 4 mice in each cage received morphine (i.e., morphine 
only). Of these morphine only mice, some received CNO (hM3D-CNO) and some 
received vehicle (hM3D-Veh). I also included control mice carrying the Cre-dependent 
AAV-hSyn where all 4 mice in the cage received morphine (i.e., morphine only) and 
CNO (CON-CNO). All morphine-treated mice were examined for spontaneous 
withdrawal symptoms 4, 8, 24, and 48 hours following the final morphine injection. 
 59 
 
 Similar to Chapter III, three days following the final dose of morphine 
pretreatment, CPP acquisition began.  Following the second test session, extinction 
sessions began and was ran until animals reached the extinction criteria described above.  
Extinction sessions lasted for 30 minutes for the first 15 days, and 60 minutes for the 
second 15 days. This is because I have previously seen (Bates et al., 2014) that even 
morphine only animals will extinguish using extinction sessions that last for 60 minutes. 
If an animal did not reach the extinction criteria after 30 days, the extinction sessions 
were ended. 
 
6.2.7 Statistical Analysis 
6.2.7.1 Spontaneous Withdrawal Symptoms 
 The effect of inhibiting or activating MRGPRB4+ neurons on the number of jumps 
following the cessation of morphine administration was analyzed using a split-plot 
ANOVA (SPSS Statistics 18, Somers, NY) with a between-group factor of experimental 
group (hM4D-CNO, hM4D-Veh, CNO-CNO or hM3D-CNO, hM3D-Veh, CNO-CNO) 
and a within-group factor of time (4, 8, 24, and 48 hours). The total number of jumps 
across the entire 4 time periods tested was also analyzed using a one-way ANOVA with a 
between-group factor of the experimental group. Post hoc contrasts between each 
treatment group were computed using Bonferroni post hoc procedure. Differences with p-
values of less than 0.05 were deemed statistically significant.  Results are presented as 
mean ± SEM. 
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6.2.7.2 Conditioned Place Preference 
 Conditioned place preference was determined as the difference in the time spent 
in the morphine-paired chamber on the test day, and time spent in the morphine-paired 
chamber on the baseline sessions. In other words, a difference score was calculated 
between how long the animal was in the morphine-paired chamber on test day, and how 
much time it spent in the saline-paired chamber on test day. In order to reduce variance 
within each time point, the raw data underwent a log transformation. Differences in 
preference were analyzed using a split-plot ANOVA (SPSS Statistics 18, Somers, NY) 
with a between-group factor of experimental group (hM4D-CNO, hM4D-Veh, CNO-
CNO or hM3D-CNO, hM3D-Veh, CNO-CNO) and a within-group factor of time.  
Extinction criterion was defined as the first days of 3 consecutive days in which a mouse 
did not display preference for the morphine-paired chamber.  Survival scores for the 
number of mice per treatment condition that met criterion using the Kaplan-Meier 
survival estimation were computed.  Differences between the experimental groups were 
analyzed using the Breslow (Generalized Wilcoxon) test. Differences with p-values of 
less than 0.05 were considered statistically significant. 
 
6.3 Results 
6.3.1 The effect of inhibiting the activity of sensory MRGPRB4-expressing neurons on 
withdrawal-precipitated jumping behaviors in morphine cage-mate animals 
 Morphine cage-mate animals, in which the activity of sensory MRGPRB4-
expressing neurons was inhibited by CNO (hM4D-CNO, n=14), displayed significantly 
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more jumps following the cessation of morphine administration as compared to two 
varieties of control morphine cage-mate animals - morphine cage-mate mice carrying the 
AAV-hM4D but that did not receive CNO (hM4D-Veh, n=10), and morphine cage-mate 
animals carrying a control AAV and receiving CNO (CON-CNO, n=15) (Figure 9A). 
Number of jumps between the various experimental groups were recorded and compared 
at 4, 8, 24, and 48 hours after the last morphine injection. Two-way repeated ANOVA 
revealed a significant main effect of experimental group (F(2, 36) =8.90, p< 0.001), a 
significant main effect of time (F(1, 36) =10.52, p< 0.01), and a significant interaction 
between experimental group and time (F(2, 36) =3.28, p< 0.05). Similarly, one-way 
ANOVA revealed a significant main effect of experimental group (F(2, 36) =8.90, p< 
0.001) for the total number of jumps across the 4 time periods tested. Bonferroni post-
hoc comparison revealed that the hM4D-CNO group displayed significantly higher 
number of jumps as compared to the control groups. 
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Figure 9. The number of jumping behaviors displayed. (A) Morphine-treated 
MRGPRB4-Cre mice that were transfected with hM4D or control AAV, injected with 
CNO or vehicle, and housed as morphine cage-mates. (B) Morphine-treated MRGPRB4-
Cre mice that were transfected with hM3D or control AAV, injected with CNO or 
vehicle, and housed as morphine only mice. * indicates significant difference (p < 0.05) 
from control groups. Results are presented as mean ± SEM. 
 
 
 
6.3.2 The effect of activating the activity of sensory MRGPRB4-expressing neurons on 
withdrawal-precipitated jumping behaviors in morphine only animals 
Morphine only animals in which the activity of sensory MRGPRB4-expressing 
neurons was stimulated by CNO (hM3D-CNO, n=25) did not significantly differ in the 
number of jumps displayed following the cessation of morphine administration as 
compared to two kinds of control morphine only animals - morphine only mice carrying 
 63 
 
the AAV-hM3D but do not receive CNO (hM3D-Veh, n=19), and morphine only 
animals carrying a control AAV and receiving CNO (CON-CNO, n=19) (Figure 9B). 
Number of jumps between the various experimental groups were recorded and compared 
at 4, 8, 24, and 48 hours after the last morphine injection. Two-way repeated-measures 
ANOVA revealed a significant main effect of time (F(1, 60) =27.08, p< 0.0001), but no 
significant main effect of experimental group (F(2, 60) =1.98, p = 0.15, NS), and no 
significant interaction between experimental group and time (F(1, 60) =2.96, p = 0.06, 
NS). Similarly, one-way ANOVA revealed no significant main effect of experimental 
group (F(2, 60) =1.91, p = 0.16, NS) for the total number of jumps across the 4 periods 
tested.  
 
6.3.3 The effect of inhibiting the activity of sensory MRGPRB4-expressing neurons on 
conditioned place preference in morphine cage-mate animals 
 Mice that expressed hM4D and were treated with CNO (hM4D-CNO) (247.78 ± 
40.65), mice that expressed hM4D and were treated with vehicle (hM4D-Veh) (224.35 ± 
35.26), and mice that expressed mCherry and were treated with CNO (CON-CNO) 
(230.04 ± 30.84) show comparable levels of CPP acquisition during the conditioning 
phase of the experiment (F(2,26) = 0.039, NS). There were also no differences in the 
percentages of the animals that acquired CPP (Kruskal-Wallis: χ2 (2) = 0.69, NS). 
Moreover, ten hM4D-CNO mice (47%), four hM4D-Veh (36%), and six CON-CNO 
(35%) animals did not acquire CPP and were omitted from the study.  
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After acquisition was established, animals underwent the CPP extinction 
procedure.  There was a significant main effect of the time it took for the animals to no 
longer display a preference for the morphine-paired chamber (F(9,306) = 5.14, p<0.001), 
which suggests that all groups did eventually extinguish (Figure 10).  However, there 
was not a significant effect of group (F(2,34) = 1.25, NS), nor was there a significant 
interaction between time and group (F(18,306) = 1.13, NS). 
A Kaplan-Meier survival analysis showed that there were no differences among 
the groups in the rate at which they reached extinction criteria (Breslow (Generalized 
Wilcoxon): χ2(2) = 1.13, NS) (Figure 11). Also, after 30 days of daily extinction 
sessions, 45.5% of animals in the hM4D-CNO group reached extinction, while 42.9% of 
animals in the hM4D-Veh group reached extinction criteria.  Lastly, 36.4% of animals in 
the CON-CNO group displayed extinction. 
Figure 10. The log transformation of the mean preference for the morphine-paired 
chamber in animals housed as morphine cage-mates that had activity at MRGPRB4+ 
neurons inhibited.  hM4-CNO animals (dark purple line), hM4-Veh (magenta line), and 
CON-CNO (gray line) subjected to up to 30 daily extinction sessions. Sessions lasted for 
30 min. on days 1-15, and 60 min. on days 16-30. Results are presented as mean ± SEM. 
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Figure 11. The number of animals, and the rate, to achieve extinction criteria over the 
30 days of extinction procedure in the morphine cage mates that had activity at 
MRGPRB4+ neurons inhibited.  hM4-CNO animals (dark purple line), hM4-Veh 
(magenta line), and CON-CNO (gray line). 
6.3.4 The effect of activating the activity of sensory MRGPRB4-expressing neurons on 
conditioned place preference in morphine only animals 
Mice that expressed the hM3D virus and were treated with CNO (hM3D-CNO) 
(198.5 ± 17.38), mice that expressed the hM3D virus and were treated with vehicle 
(hM3D-Veh) (293.2 ± 28.6), and mice that expressed the mCherry virus and were 
treated with CNO (CON-CNO) (257.7 ± 35.6) show a significant difference in levels of 
CPP acquisition during the conditioning phase of the experiment (F(2,37) = 3.83, 
p<0.05). This was due to the finding that acquisition in the hM3D-CNO group was 
significantly lower than the hM3D-Veh group (p<0.05). Also, there was a trend for 
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significance between the hM3D-CNO group and the CNO-CON group (p=0.15). 
However, there was no difference between the hM3D-CNO and the CON-CNO groups 
(NS).  There were also no differences among the experimental groups in the percentages 
of the animals that acquired CPP (Kruskal-Wallis: χ2 (2) = 2.31, NS). Thirteen hM3D-
CNO mice (45%), eight hM3D-Veh (40%), and seven CON-CNO (35%) animals did not 
acquire CPP and were omitted from the study.  
After acquisition was established, the animals underwent the CPP extinction 
procedure.  There was a significant main effect of the time it took for the animals to no 
longer display a preference for the morphine-paired chamber (F(9,333) = 8.76, p<0.001), 
which suggests that all groups did eventually extinguish (Figure 12).  There was also a 
significant effect of group (F(2,37) = 3.83, p<0.05). Similarly, there was a significant 
interaction between time and group (F(18,333) = 2.05, p<0.01).  This significant time × 
group interaction was driven by the decreased rate of acquisition in hM3D-CNO 
animals, as well as the significant difference (F(2,37) = 3.94, p<0.05) at the first 
timepoint between the hM3D-CNO and the CON-CNO groups (p<0.05).  No other 
significant differences were observed between the experimental groups at any time 
point. 
 A Kaplan-Meier survival analysis showed that there were no differences among 
the groups in the rate at which they reach extinction criteria after daily extinction 
sessions (Breslow (Generalized Wilcoxon): χ2(2) = 0.47, NS) (Figure 13). Also, after 30 
days of daily extinction sessions, 43.8% of animals in the hM3D-CNO group reached 
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extinction, while 41.7% of animals in the hM3D-Veh group reached extinction criteria.  
Lastly, 38.5% of animals in the CON-CNO group displayed extinction. 
 
 
 
Figure 12. The log transformation of the mean preference for the morphine-paired 
chamber in animals housed as morphine only that had activity at MRGPRB4+ neurons 
activated.  hM3-CNO animals (dark red line), hM3-Veh (red line), and CON-CNO (gray 
line) subjected to 30 daily extinction sessions. Sessions lasted for 30 min. on days 1-15, 
and 60 min. on days 16-30. Results are presented as mean ± SEM. 
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Figure 13. The number of animals, and the rate, to achieve extinction criteria over the 
30 days of extinction procedure in the morphine only animals that had activity at 
MRGPRB4+ neurons activated.  hM3-CNO animals (dark red line), hM3-Veh (red line), 
and CON-CNO (gray line). 
 
 
6.4 Discussion 
This study demonstrated that social grooming modulates the role of social 
housing conditions on morphine dependence.  Specifically, MRGPRB4-Cre mice that 
were transfected with Gi-DREADD, treated with CNO, and housed as morphine cage-
mates (hM4D-CNO) showed more withdrawal symptoms than did control mice housed 
in the same condition. These results suggest that reducing the sensation of social 
grooming by decreasing activity at MRGPRB4+ neurons has the ability to affect the 
previously observed social housing effect.  As jumping behavior has been shown to 
indicate morphine dependence, these data show that CNO-treated mice developed 
stronger morphine dependence than control mice.  
In this study, I observed a trend in which morphine cage-mate MRGPRB4-Cre 
mice transfected with Gi-DREADD, treated with CNO took longer to extinguish 
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morphine CPP than control animals. The time to extinguish a place preference has been 
associated with increased drug reward (Kaplan & Coyle, 1998; X. Ma et al., 2012; Self 
& Choi, 2004) and more robust memories of the cues that are associated with drug 
addiction. However, this observation did not reach statistical significance. My previous 
results demonstrate that mice that received morphine while being housed with drug-
naïve mice (i.e. morphine cage-mates) express less jumping behavior and extinguish 
CPP more rapidly than mice that receive morphine but are exposed only to other 
morphine-injected animals (morphine only). Therefore, the findings in this study provide 
evidence for a role of social grooming in, at least some of, the protective effect of being 
housed with drug-naïve mice. 
In this experiment, I also examined the effect of activating MRGPRB4+ neurons 
in animals housed in the morphine only condition.  Activation of MRGPRB4+ reduced 
acquisition of CPP in the hM3D-CNO group. This may be because activation of these 
neurons was found to be rewarding in young animals (Vrontou et al., 2013).  Moreover, 
social grooming and social play have been shown to be rewarding in adolescent animals 
(van Kerkhof et al., 2013).  However, contrary to my hypothesis, these animals did not 
show any differences in withdrawal symptoms, or the extinction of CPP, as compared to 
the controls. It was expected that activation of the sensation of grooming would increase 
the rate of extinction of morphine CPP.  However, I chronically administered CNO twice 
daily.  There may have been excessive stimulation to these animals that was similar to 
social crowding, a form of social stress (Beery & Kaufer, 2015). This involves 
increasing the number of animals relative to the available cage area. It can be 
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accomplished by housing animals in smaller cages, by increasing the number of animals 
per cage, or by a combination of both. Similar to the reaction to social stress resulting 
from isolation, social stress as a result of social crowding was also suggested to increase 
the release of endogenous opioid peptides. Specifically, rodents show aversion to food 
presented in association with the administration of opioid antagonists, such as naloxone. 
Social crowding enhanced these aversive properties of naloxone, suggesting that social 
crowding increases endogenous opioid tone (Pilcher & Jones, 1981).  Therefore, chronic 
activation of MRGPRB4+ neurons may have been an aversive stimulus that leads to a 
heightened response to opioids, which resulted in the lack of differences between control 
and treatment mice. Because this is the first to examine how MRGPRB4+ neuronal 
activity contributes to opioid reward, there is not much literature on this subject.  
In my previous paper on morphine dependence and the extinction of CPP (Bates 
et al., 2014), I argued that housing conditions might modulate morphine dependence and 
reward because of differences in the quality of social interaction between the morphine-
treated animals and between the drug-naïve animals and their morphine cage-mates.  In 
this experiment, I attempted to study this by modulating activity at neurons expressing 
receptors known to be involved in social grooming.  Grooming of a conspecific is a form 
of positive, affiliative social interaction in mice. Moreover, oxytocin enhances grooming 
behavior in mice, and this effect may be dependent on dopaminergic activity in the 
nucleus accumbens (Filippo Drago, Caldwell, et al., 1986; F. Drago, Pedersen, et al., 
1986), suggesting that grooming activates reward circuitry and that oxytocin may play a 
role in grooming behavior.   Oxytocin induces profound prosocial effects in both humans 
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and non-human animals, including increases in the salience of social stimuli, as well as 
increases in the time spent interacting with conspecifics in a social interaction test 
(Domes et al., 2007; Lukas et al., 2011). Conversely, oxytocin and oxytocin-receptor 
(OT-R) knockout mice show deficits in social recognition (Choleris et al., 2006; 
Ferguson et al., 2000; Takayanagi et al., 2005).  Moreover, systemic administration of 
oxytocin has been shown to attenuate symptoms associated with withdrawal from 
opioids, including heroin and morphine (e.g. jumping and piloerection) (Kovacs, 
Borthaiser, & Telegdy, 1985; Kovacs, Horvath, et al., 1985; Kovacs et al., 1984; Kovacs 
& Marko, 1993).  Similarly, systemic, as well as local nucleus accumbens and 
hippocampus, injections of oxytocin decreased the acquisition and maintenance of 
heroin self-administration in heroin-dependent adult animals (Ibragimov et al., 1987; 
Szabo et al., 1985).  Therefore, it is possible that social grooming induces oxytocin, 
which, in the morphine cage-mates, helps to ameliorate the effects of receiving chronic 
opioids.  By blocking the sensation of social grooming, oxytocin activity may have been 
blocked. Future studies should examine the role that oxytocin plays in the social housing 
effect, and how social grooming affects oxytocin. Moreover, oxytocin should be 
measured using MRGPRG4-Cre mice to see if blocking the sensation of social grooming 
produces differences in oxytocin levels. 
It is known that early social environment plays a role in the propensity to abuse 
drugs (Bardo et al., 2013).  Moreover, it has been shown that social support can also be a 
factor that aids in the cessation of use of both licit and illicit drugs (Kelly et al., 2008; 
Klimas et al., 2014; Luchenski et al., 2015; McCutcheon et al., 2016).  One form of 
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affiliative social behavior in the rodent is through social grooming. In this experiment, I 
attempted to manipulate the sensation of social grooming in adolescent mice. Blocking 
this sensation might reduce the protective effect of being housed with drug-naïve mice. 
Adolescent opioid abuse is on the incline, and current treatments are not effective in 
reducing rates of relapse. Thus, the present data represent an avenue that needs to be 
further elaborated, and could hold benefits for the treatment of human addiction.  In the 
following experiment, I examine the role that vasopressin may have in the social housing 
effect, as it has been implicated in pair-bonding and social interaction. 
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CHAPTER VII 
EXPERIMENT 5: VASOPRESSIN’S ROLE IN THE SOCIAL HOUSING EFFECT 
 
7.1 Introduction 
Vasopressin is synthesized in the hypothalamus, and is secreted from the 
posterior pituitary into the blood stream, and into the central nervous system (Barberis & 
Tribollet, 1996).  It can also contain arginine, and this form is referred to as arginine-
vasopressin (AVP).  Peripherally, vasopressin’s main role is to facilitate the reabsorption 
of water into the kidney, and to induce contraction of the smooth muscle that surrounds 
arteries. When released into the brain, AVP’s effects are manifold, including activation 
of corticotropin-releasing factor (CRF).  It produces these distinct effects by its actions 
on three receptors, V1a (primarily liver, smooth muscle, and brain), V1b (pituitary and 
various locations in the brain), and V2 (primarily in the kidney).  It is suggested that 
vasopressin may act as a neuromodulator in brain regions that are implicated in 
addiction, including the mesolimbic pathway, as AVP binding sites have been located in 
this region (Buijs, 1983; de Kloet et al., 1985). 
 The AVP system is important to drug addiction research for a variety of reasons.  
AVP release is triggered in response to stress and activation of V1b receptors produce 
ACTH secretion in the anterior pituitary.  Importantly, vasopressin has also been shown 
to play a role in social cognition, recognition, and affiliation (Insel, 2010). AVP is 
expressed in regions that have been implicated in social anxiety, and its actions are 
associated with male-typical social behaviors, including pair bonding, courtship, 
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intermale aggression, and scent marking (Lim & Young, 2006).  Also, increasing the 
number of vasopressin receptors in the brain increases social interaction in adult rats 
(Landgraf et al., 2003).  It seems that AVP is involved in pairing stress and anxiety with 
social cues.  Therefore, AVP is a suitable candidate for exploring the role that social 
environment plays in addiction.  
There is developing consensus that AVP has a role in opioid-induced drug-taking 
and drug-seeking.  Treatment with AVP facilitates the development of morphine 
physical dependence, and acute treatment with morphine decreases plasma levels of 
AVP (Van Ree & De Wied, 1977c; van Wimersma Greidanus et al., 1979).  Acute 
treatment with morphine does not alter AVP levels in the hippocampus, while morphine 
dependent mice display decreased levels of AVP in this area (Kovacs et al., 1987).  It 
appears that opioid history is also important concerning AVP.  Regarding the findings in 
the hippocampus, the decreased levels of AVP likely represent the development of 
morphine tolerance, as vasopressin receptors in the hippocampus have been shown to 
mediate this effect (Su et al., 1998).   
AVP decreases intravenous self-administration of heroin when administered both 
systemically, and through an intracerebroventricular injection (van Ree, Burbach-
Bloemarts, & Wallace, 1988; van Ree & de Wied, 1977a, 1977b).  Moreover, removing 
AVP with anti-vasopressin serum facilitated heroin self-administration (Van Ree & De 
Wied, 1977c).  An increase in AVP mRNA in the amygdala was observed in the early, 
but not the late, withdrawal phase following heroin administration (Zhou et al., 2008).  
This was accompanied by increased levels of plasma corticosterone, suggesting a 
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relationship between AVP and stress during opioid withdrawal. The distinction between 
early and late withdrawal in Zhou et al. (2008) was 12 hours and 10 days, respectively.  
This was an important distinction to examine because, the most salient states of 
spontaneous withdrawal are observed within the first 24-hour period in rodents (Mucha, 
Gritti, & Kim, 1986). This finding is consistent with previous results showing HPA axis 
activation during early opioid withdrawal.  Moreover, blockade of the AVP V1b 
receptor decreased both the stress and heroin-primed reinstatement of heroin self-
administration (Zhou et al., 2008). This might suggest that stress may be involved in 
reinstatement, but it is important to note that AVP mRNA in the amygdala was only 
increased in heroin-dependent, but not heroin-naïve animals. Therefore, there is an 
interconnection between a stressor’s ability to produce heroin-seeking and previous 
heroin experience.   Also, if taken together with Kovacs et al. (1987)’s findings, it seems 
that, concerning heroin, AVP is only produced during withdrawal. 
Previously, it was found that morphine only animals acquire morphine CPP more 
readily than morphine cage-mates (Cole et al., 2013). Because of AVP’s role in social 
relationships, as well as its ability to modulate opioid-induced processes, I sought to 
explore a possible role for AVP in the observed social housing effect. I assessed the 
acquisition of morphine CPP after blockade of AVP receptor V1b, as well as mRNA 
expression of AVP in the striatum among the various groups. 
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7.2 Methods 
7.2.1 Animals 
All procedures were conducted in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals, and were approved by the 
Institutional Animal Care and Use Committee. The mice used were outlined in Chapter 
II. Briefly, adolescent C57BL/6 male mice were purchased from Envigo (Houston, TX) 
and acclimated to the colony for a minimum of 5 days before the start of experiments. 
 
7.2.2 Housing conditions 
Mice were housed in conditions as outlined in Chapter II. Briefly, they were 
housed as saline only (SAL), saline cage-mates (SCM), morphine cage-mates (MCM), 
or morphine only (MOR).  
 
7.2.3 Morphine pretreatment regimen 
In the real-time PCR study, mice were injected with 20 mg/kg morphine (10 
ml/kg, s.c.) or saline once daily for 14 days. This dose represents the salt concentration. 
Mice were then euthanized and their dorsal striatum were dissected 24 hours following 
the final injection of morphine. In the behavioral study, similar to previous studies (Cole 
et al., 2013; Hodgson et al., 2010), mice were injected twice daily (9:00 am and 5:00 
pm) in their home cage for 6 consecutive days with increasing doses of morphine (10–40 
mg/kg, 10 ml/kg, s.c.) or saline for a total of 12 injections. Specifically, on days 1 and 2, 
the mice were injected with 10 mg/kg morphine or saline. On days 3 and 4, they were 
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injected with 20 mg/kg morphine or saline. On days 5 and 6, they were injected with 40 
mg/kg morphine or saline. Morphine sulfate was purchased from Sigma (St. Louis, MO, 
USA).   
 
7.2.4 RNA preparation and qPCR 
 Total RNA was isolated from homogenates of the dorsal striatum using the 
miRNAeasy Lipid Tissue mini kit (Qiagen, Valencia, CA) according to assay 
instructions and total RNA was quantified using a Nanodrop 1000 spectrophotometer 
(ThermoScientific, Waltham, MA).  Extracted RNA was transformed into cDNA using 
supplies from New England Biolabs (Ipswich, MA) according to assay instructions.  
qRT-PCR was used to measure gene expression results. The PCR primer for 
AVP was designed using NCBI Reference Sequences, and was designed to have a Tm of 
~ 60oC. Quantitative RT-PCR was conducted using SYBR® Green JumpStart ReadyMix 
(Sigma-Aldrich, Missouri, MO) on a StepOnePlus™ Real-Time PCR System (Applied 
Biosystems, Carlsbad, CA).  AVP primer (Table 2) was purchased from Eurofins mwg 
Operon (Huntsville, AL). Differences among groups were calculated using the ΔΔCt 
method.  
 
 
Table 2. AVP Primer 
Gene: Sequence: 
AVP F: 5’-TCCGTGGATTCTGCCAAGC-3’ 
R: 5’-AAGTTTATTTTCCATGCTGTAGGG-3’ 
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7.2.5 CPP apparatus 
Morphine CPP was conducted in a set of eight identical apparatuses. The 
specifications of the apparatus are described in Chapter III. On habituation and test 
sessions, two doors allowed free access between the three chambers, while on 
conditioning days, animals were confined to one of two chambers.  Also, on habituation 
and test sessions, the animals were placed directly into the neutral chamber.  Each day, 
mice were habituated to the testing room for 30 minutes prior to being placed in the 
apparatus. The CPP apparatus was thoroughly cleaned with 70% ethanol and water and 
completely dried between mice. 
 
7.2.6 Morphine CPP experimental design 
Seven days following the final home cage treatment dose of morphine or saline 
(i.e. experimental day 13), mice (n=10-20 per experimental group) were placed in the 
neutral chamber and permitted free access to the entire apparatus for 30 minutes. The 
time spent in each of the chambers was recorded to measure any initial bias. Animals 
that spent more than 70% of the time in one chamber were eliminated from the study. 
The following 2 days, each animal had two conditioning sessions, one session per day. A 
biased design was used for this study wherein, for each mouse, the chamber that was less 
preferred in the initial recording was assigned to be the drug-paired chamber for that 
mouse. For one conditioning session, animals were injected with 20 mg/kg morphine or 
saline and were confined for 60 minutes to the less preferred conditioning chamber. For 
the other conditioning session, animals were injected with saline and were confined for 
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60 minutes to the other chamber. Animals from each treatment group were randomly 
assigned to receive a morphine conditioning session on experimental day 14 or 15, 
ensuring that from each treatment group and conditioning dose half of the animals 
received the morphine conditioning session on experimental day 14, and the other half 
received the morphine conditioning session on day 15. The following day (i.e. 
experimental day 16), mice in a drug-free state were allowed to freely explore the 
apparatus for 30 minutes. The time spent in each chamber was recorded to the nearest 
second.  
 
7.2.7 Data Analysis 
The differences in gene expression between groups were analyzed using a two-
way ANOVA (SPSS Statistics 18, Somers, NY) with between-group factors of housing 
and treatment for each gene. Post hoc contrasts between each treatment group were 
conducted using the Bonferroni procedure. 
Conditioned place preferences are reported as the differences in the time spent in 
a compartment between post- and pre-conditioning sessions. The data was than 
subjected to a log10 transformation (Kirk, 1968) and analyzed using a two-way ANOVA 
with the conditioning (morphine vs. saline) and AVP-V1b receptor antagonism 
(SSR149415 vs. vehicle) as variables. Post hoc contrasts between each treatment group 
were computed using the Bonferroni procedure. Differences with p-values of less than 
0.05 were deemed statistically significant.   
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7.3 Results 
7.3.1 Housing with drug-naïve animals protect against morphine-induced increase in 
AVP expression 
I used qPCR to examine AVP mRNA expression in the striatum following 
repeated administration of morphine in animals that were differentially housed.  AVP 
expression in animals housed in the morphine only condition was much higher than all 
other groups (Figure 14). A two-way ANOVA revealed a significant main effect of 
treatment (F(1,34) = 4.24, p< 0.05).  Moreover, there was a strong trend for a main 
effect of housing (F(1,34) = 3.96, p = 0.055), as well as a significant interaction between 
housing and treatment (F(1,34) = 3.75, p = 0.06).  Bonferroni post hoc analyses 
demonstrated that morphine only mice exhibit higher gene expression than animals 
housed as morphine cage-mates (morphine only vs. morphine cage-mates, p = 0.035).  
They also exhibit higher expression of AVP than saline-treated animals (morphine only 
vs. saline only, p = 0.038; morphine only vs. saline cage-mates, p = 0.034). 
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Figure 14.  Gene expression of AVP in the striatum. Saline only, n = 9; saline cage 
mates, n = 9; morphine cage-mates, n = 10; and morphine only, n = 10. * indicates a 
significant difference from the other experimental groups. Results are represented as 
means ± SEM. 
  
 
 
7.3.2 Inhibition of AVP-V1b receptor inhibits the development of morphine CPP in 
morphine only animals 
SSR149415 inhibited the development of morphine CPP in morphine only 
animals (Figure 15A). Two-way ANOVA revealed a significant main effect of 
conditioning (F(1, 56) =7.93, p< 0.01). There was no significant main effect of AVP-
V1b receptor antagonism (F(1, 56) =3.07, p = 0.085), but there was a significant 
interaction between conditioning and AVP-V1b receptor antagonism (F(1, 56) =4.39, p< 
0.05). Bonferroni post-hoc comparison revealed that injection of SSR149415 30 minutes 
prior to the conditioning session did not alter the acquisition of CPP in animals 
conditioned only to saline (MOR-SSR-saline vs. MOR-vehicle-saline, NS). As expected, 
morphine only animals receiving vehicle and conditioned to morphine acquired 
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significant morphine CPP as compared to morphine only animals receiving vehicle that 
were conditioning only with saline (MOR-vehicle-morphine vs. MOR-vehicle-saline, p< 
0.01). In contrast, morphine only animals receiving SSR149415 and conditioned to 
morphine did not acquire significant morphine CPP as compared to controls (MOR-
SSR-morphine vs. MOR-vehicle-saline or MOR-SSR-saline, NS). Moreover, acquisition 
of morphine CPP was significantly reduced in MOR-SSR-morphine animals relative to 
MOR-vehicle-morphine animals (p< 0.05).  
 
 
Figure 15. Mice were treated with morphine for 6 days and housed as morphine only 
(A) or morphine cage-mates (B). Subsequently, they were tested for the acquisition of 
CPP. They were conditioning in the drug-paired chamber with 20 mg/kg morphine or 
saline (controls). SSR149415 (SSR) or vehicle (Veh) were administered 30 minutes 
prior to the conditioning session. * indicates significant difference p < 0.05; ** indicates 
significant difference p < 0.01.  from control groups. Results are presented as mean ± 
SEM. 
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7.3.3 Inhibition of AVP-V1b receptor did not alter the development of morphine CPP in 
morphine cage-mate animals 
Morphine cage-mates acquired significant morphine CPP, when conditioning 
with morphine vs. saline (Figure15B). Two-way ANOVA revealed a significant main 
effect of conditioning (F(1, 39) =5.47, p< 0.05). However, SSR149415 did not alter the 
acquisition of morphine CPP. Two-way ANOVA revealed no significant main effect of 
AVP-V1b receptor antagonism (F(1, 39) =0.18, NS), and no significant interaction 
between conditioning and AVP-V1b receptor antagonism (F(1, 39) =0.53, NS). 
Bonferroni post-hoc comparison revealed no significant different between the various 
experimental groups. 
 
7.4 Discussion 
 In the present experiment, pharmacological antagonism of the AVP system via 
the V1b receptor resulted in decreased morphine reward in animals housed in the 
morphine only condition, but not animals housed as morphine cage-mates.  Moreover, 
striatal AVP expression was increased in morphine only mice, but not in the morphine 
cage-mates.  This suggests that housing with drug-naïve animals protects from 
morphine-induced increases in AVP expression. It provides evidence for vasopressin’s 
role in the social housing effect.   
 As mentioned above, AVP has been shown to modulate opioid reward and 
dependence (van Ree et al., 1988; van Ree & de Wied, 1977b, 1977c).  Moreover, 
antagonism of V1b receptor decreases heroin reinstatement (Zhou et al., 2008).  
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Therefore, my results align with previous findings that suggest vasopressin’s role in 
opioid-induced reward and dependence.   
 Additionally, in line with the findings of the CPP experiment, I show that AVP 
gene expression in the striatum of morphine only animals was increased compared to all 
other groups.  AVP mRNA was shown to be increased in the amygdala and 
hypothalamus during early heroin withdrawal – a time point that was similar to the time 
point used in this experiment (Zhou et al., 2008).  Similarly, AVP was shown to be 
increased in the nucleus accumbens following chronic exposure to cocaine (Rodriguez-
Borrero et al., 2010).  Therefore, the present results are consistent with previous 
literature on AVP expression following chronic exposure to drugs of abuse. 
 The observed increase in expression of vasopressin could be due to augmented 
levels of stress (Tanaka, Versteeg, & De Wied, 1977). Morphine withdrawal increases 
corticosterone release and is stressful (Hofford et al., 2011). Moreover, vasopressin has 
been correlated with the increased stress that accompanies morphine withdrawal (Nunez 
et al., 2007). However, there were not any differences in corticosterone levels among 
groups during the time point that CPP was conducted in this study (Cole et al., 2013). 
Therefore, while it is unlikely that stress is the only reason that V1b antagonism 
decreased the acquisition of morphine CPP in morphine only mice, it may contribute to 
it. 
 The V1b antagonist, SSR419145, was administered systemically.  Thus, its site 
of action is unable to be determined.  While the results here suggest differences in 
striatal AVP expression levels, it is possible that the site of action for the V1b 
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antagonism is not the striatum.  This is due to the fact that V1b expression is low in the 
striatum and other portions of the midbrain (Vaccari, Lolait, & Ostrowski, 1998).  
Moreover, V1b is abundantly expressed in many other areas of the brain, including the 
amygdala, which is involved in the stress response induced by vasopressin (Vaccari et 
al., 1998).  Additionally, receptors for AVP exist both in the CNS and peripherally.  
Future studies should use local injections of V1b, and V1a, antagonists to measure their 
effect on morphine CPP. 
 Previously, it was shown that morphine only animals acquire morphine CPP after 
a single exposure to morphine, while morphine cage-mates do not.  In this experiment, I 
found that antagonism of the vasopressin V1b receptor reduced the expression of 
morphine CPP in morphine only animals, but did not affect morphine cage-mates. 
Moreover, gene expression of AVP in the striatum was significantly higher in morphine 
only animals than any other group, including morphine cage-mates.  Therefore, the 
results here demonstrate vasopressin’s role in the social housing effect on acquisition of 
opioid reward.  Vasopressin represents one possible neurobiological mechanism 
mediating the social housing effect on opioids’ abuse liability. In the next experiment, I 
explore other possible mechanisms. 
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CHAPTER VIII 
EXPERIMENT 6: SOCIO-ENVIRONMENTAL EFFECT ON GENE EXPRESSION IN 
THE ADOLESCENT MOUSE STRIATUM 
 
8.1 Introduction 
 Morphine addiction involves many brain regions. Multiple theories propose that 
addiction involves the recruitment of brain regions implicated in natural reward and 
motivation to seek reward (Koob, 1992a; Robinson & Berridge, 1993).  It is thought that 
after these areas become recruited, they become hypersensitive to drugs and related 
stimuli.  One of the more notable regions involved in reward is the mesocorticolimbic 
pathway, which is integral in dopaminergic transmission, and includes the striatum, 
ventral tegmental area (VTA), and prefrontal cortex (PFC).  Importantly, opioids 
activate opioid receptors located on GABAergic neurons in this pathway, thus activating 
dopaminergic neurons in the striatum to produce the effects associated with opioid use.   
There is evidence showing that opioids alter gene expression in several brain 
regions implicated in addiction in adult rodents (Georges et al., 1999). Specifically, there 
are several studies suggesting alterations in the striatum (Jacobs et al., 2013; Korostynski 
et al., 2007; Ziolkowska et al., 2012). Nevertheless, there is a dearth of information in 
the literature regarding the effects of opioids, particularly morphine, on alterations in 
gene expression in the adolescent brain (Ellgren, Spano, & Hurd, 2007). For example, 
adolescent mice trained to self-administer oxycodone display differential patterns of 
gene expression than adults, in both the dorsal striatum and the hippocampus (Mayer-
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Blackwell et al., 2014; Zhang et al., 2015). Interestingly, it was found that more genes 
were altered in the dorsal striatum of adolescents than adults, which may suggest a 
unique plasticity of adolescent brains to opioid exposure. 
Moreover, despite the preponderance of behavioral evidence, little is known 
about the interaction between opioids and environment in the effects on gene expression. 
Therefore, in the current study, I examined the role of social environment on morphine-
induced modulation of striatal gene expression, an area that has been shown to be 
involved in opioid reward and addiction.  Given that housing with drug-naïve animals 
protects against the acquisition of opioid reward, I hypothesized that housing with drug-
naïve animals will protect against morphine-induced modulation of striatal gene 
expression, resulting in significant differences in morphine-induced gene expression 
between morphine only and morphine cage-mate animals. 
 
8.2 Methods 
8.2.1 Animals 
Adolescent, male mice were used in this experiment. There were 10 animals per 
group. Animals were housed according to the housing conditions outlined in the general 
methods: saline only, mixed cage (saline or morphine cage-mates), or morphine only. 
 
8.2.2 Pretreatment Regimen 
Mice were pretreated once daily with saline or 20 mg/kg morphine (10 mg/mL, 
s.c.) at 9:00AM for fourteen days.  This dose represents the salt concentration. 
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8.2.3 Tissue Collection 
 Twenty-four hours following the final morphine injection, mice were deeply 
anesthetized with sodium pentobarbital (100 mg/kg, 10 mg/mL, i.p.).  Brains were 
extracted, and flash-frozen, in a bath of 2-methylbutane cooled on dry ice.  Dorsal 
striatum tissue was dissected out of the flash-frozen brains and stored at -80oC until 
RNA extraction.   
 
8.2.4 RNA Extraction 
Total RNA was isolated from homogenates of the dorsal striatum using the 
miRNAeasy Lipid Tissue mini kit (Qiagen, Valencia, CA) according to assay 
instructions and total RNA was quantified using a Nanodrop 1000 spectrophotometer 
(ThermoScientific, Waltham, MA).  Extracted RNA was transformed into cDNA using 
supplies from New England Biolabs (Ipswich, MA) according to assay instructions.  
 
8.2.5 RNA-Seq 
After the RNA was extracted, the samples were analyzed using high-throughput, 
next generation sequencing (RNA-Seq). The total RNA was submitted to AgriLife 
Genomics and Bioinformatics Service at Texas A&M University. Libraries were 
prepared for each sample by using the Illumina TruSeq RNA Sample Preparation Kit 
following the manufacturer’s instructions. Data was sequenced on ten lanes of Illumina 
HiSeq 2500 sequencer. The study consisted of 40 total RNA – 10 samples per group. 
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Barcoding was used to multiplex biological replicates. Base calling and data 
preparations were completed using Illumina CASAVA software.  
The data analysis started by quality control of the generated FASTQ files, using 
FastQC software (Andrews). Reads were aligned to the reference genome to locate the 
origin of each RNA fragment on the reference genome. The reference genome of mus 
musculus (mm10) and the gene annotation file was downloaded from UCSC and employ 
the Tuxedo protocol proposed by Trapnell et al. (2012). 
 
8.2.6 Real-time PCR 
 qRT-PCR was used to measure gene expression results from the RNA-Seq. All 
PCR primers were designed using NCBI Reference Sequences, and were designed to 
have a Tm of ~ 60oC. Quantitative RT-PCR was conducted using SYBR® Green 
JumpStart ReadyMix (Sigma-Aldrich, Missouri, MO) on a StepOnePlus™ Real-Time 
PCR System (Applied Biosystems, Carlsbad, CA).  All primers were purchased from 
Eurofins mwg Operon (Huntsville, AL). Differences among groups were calculated 
using the ΔΔCt method. Sequences are in Table 3:  
 
 
Table 3. Primers 
Gene: Sequence: 
β-Actin F: 5’-TCAAGATCATTGCTCCTCCTG-3’ 
R: 5’-TGTAAAACGCAGCTCAGTAAC-3’   
Bromodomain 3 (Brd3) F: 5’-GGACTCAAACCCAGACGAGATT-3’ 
R: 5’-TGTTGACAATGGTTTCCTCTGC-3’ 
Cyclin-dependent kinase 12 
(Cdk12) 
F: 5’-GTCCTCCAGCTATGAAAGGAG-3’ 
R: 5’-GGATTTCCTACTGGGGAGTG-3’ 
Phosphatidic Acid-Preferring 
Phospholipase A1 (DDHD1) 
F: 5’-GACTCCGCATTGGAACTGG-3’ 
R: 5’-CGGTATCATGCTCGTGTTTG-3’ 
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Table 3. Continued 
Gene: Sequence: 
Coagulation factor V (F5) F: 5’- CTGAATAGACGATGGCGTG-3’ 
R: 5’- TTGTTGTGTTTGTGTGAGAGG-3’ 
Dopamine D1 receptor (D1R) F: 5’- CCTGTTTTCTGTCCCTGCTTA-3’ 
R: 5’- GACACAGCTAAAGAGATGACAAAGA -3’ 
Epidermal growth factor-like 
protein 7 (Egfl7) 
F: 5’- ACCTACCGAACCATCTACCG-3’ 
R: 5’- GCATATTGCTGCTCCACAAG-3’ 
Forkhead Box J2 (FoxJ2) F: 5’-CCCAAGACTCAGCAGGATAC-3’ 
R: 5’-AAGTCCCAGTCGAAGTCATC-3’ 
Geranylgeranyl transferase 
type-2 subunit beta (Rabggtg) 
F: 5’- CTTTGATGGTGGATTTGGGTG-3’ 
R: 5’- ATCTGGTAACTTCTCGGGTC-3’ 
Glucuronic Acid Epimerase 
(Glce) 
F: 5’-GGTCCAGTATGACGGCTATG-3’ 
R: 5’-AATGGCACACCTTCAACTCC-3’ 
Guanine nucleotide-binding 
protein-like 3 (Gnl3) 
F: 5’- TGCTGACGATCAAGAAAATGG-3’ 
R: 5’- AGATGGCTTACCTGCTGTTG-3’ 
Interleukin-1 receptor-
associated kinase 1 (Irak1) 
F: 5’- TGACCCAGAGGCAAAACTCC-3’ 
R: 5’- CTTAGTTCCACAGAGCACCTCC-3’ 
Jagged 2 (Jag2) F: 5’-GTCGTCATTCCCTTTCAGTTC-3’ 
R: 5’-ATCTGGAGTGGTGTCATTGTC-3’ 
Klotho F: 5’- CCCGAATGTCTATCTGTGG-3’ 
R: 5’- CGAAGTAAGGTTATCTGAGGC-3’ 
Oxytocin receptor (OtR) F: 5’- CTGTTCTCAACCATCCTCGG-3’ 
R: 5’- AGGAGGGATGCAAACCAATC-3’ 
PDZ and LIM domain protein 
7 (Pdlim7) 
F: 5’- TCACTCTGGTGCCACAATAAAC-3’ 
R: 5’- TAACCCTCATCCTCCTCCTGTC-3’ 
Phenylalanyl-TRNA 
Synthetase Alpha Subunit 
(FARSA) 
F: 5’-TCTTCTTGGAGATGGGGTTCAC-3’ 
R: 5’-GTTTCACGCGCTGGACATAG-3’ 
Phosphodiesterase 12 (Pde12) F: 5’-ACCCATTAGCACAGGAGAAG-3’ 
R: 5’-GAGACGAATGTATCCACCTTTTG-3’ 
Platelet Derived Growth 
Factor Receptor Alpha 
(Pdgfra) 
F: 5’-TCCGGGTATCGGATTTTCTTTG-3’ 
R: 5’-ATAAGAGCTGGCAGGAGATGAG-3’ 
Rotatin (Rttn) F: 5’-TCTACTCAAGGGGTGGATAGC-3’ 
R: 5’-CCATCTCTCCGCCACAATC-3’ 
Ubinuclein-2 (Ubn2) F: 5’- ACCAATAAAACAAATGAGGAGGC-3’ 
R: 5’- CAAACTTCTCTGCAACATCCC-3’ 
Zinc Finger Protein 518a 
(Zfp518a) 
F: 5’-GGGGACCACGGCAGATAC-3’ 
R: 5’-ACAACTTAATGCCTGGACAATG-3’ 
β-Arrestin 2 F: 5’-TACACACTGGACCCATCAC-3’ 
R: 5’-ATTCACTCCTTGCGTTCAC-3’ 
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8.2.7 Statistical Analysis 
 The differential gene expression analysis for each group in the RNA-Seq was 
performed between all the pairs using Cuffdiff 2, software included as part of Cufflinks. 
Cuffdiff 2 provides corrected p-values for multiple hypothesis testing usually called q-
values. The genes were sorted based on the q-values and the False Discovery Rate 
(FDR). 
 The differences in gene expression between groups were analyzed using a two-
way ANOVA (SPSS Statistics 18, Somers, NY) with between-group factors of housing 
and treatment for each gene. Post hoc contrasts between each treatment group were 
conducted using Bonferroni post hoc procedure. 
 
8.3 Results 
8.3.1 RNA-Seq 
Over 1200 genes were altered in the morphine only animals (MOR) as compared 
to saline only animals. In contrast, only 121 genes were altered in the morphine cage-
mates (MCM), as compared to saline only animals, and only 61 of the altered genes were 
common between the morphine only and morphine cage mate animals (Figure 16). 
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Figure 16. Venn-diagram of the number of genes that were differentially regulated in 
each group as compared to saline only animals. N = 10/group. SCM = Saline Cage-
Mates, MCM = Morphine Cage-Mates, MOR = Morphine Only. 
  
 
 
 In order to determine the function of the gene targets that were identified using 
RNA-Seq, I conducted a thorough investigation using PubMed, as well as various other 
databases (e.g., GeneCards). Below is a table depicting the functions of the genes that 
were found to be altered (in the morphine-treated groups), as well which groups they 
were altered in (Table 4). 
 
 
Table 4. A table depicting the functions of the genes that were identified in the RNA-
Seq, as well as their group identification, and the direction of the gene dysregulation. 
Function 
Morphine Only Morphine CM 
Up Down Up Down 
Binding proteins 75 89 3 5 
Cellular 21 57 3 6 
Cytoskeleton 36 39 3 1 
Development 46 47 4 4 
Enzymes 111 131 6 12 
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Table 4. Continued 
Function 
Morphine Only Morphine CM 
Up Down Up Down 
Hormones 3 7 1 4 
Ion Channels 14 6 1 3 
miRNAs and other 
non-coding RNAs 
41 46 10 13 
Receptors 37 29 2 5 
Signaling 35 65 2 8 
Transcription 74 60 8 10 
Transmembrane 12 16 0 0 
Transport 31 26 0 1 
Vesicle Trafficking 9 9 0 0 
Unknown 21 31 3 3 
Total 
566 658 46 75 
1224 121 
 
 
 
 
8.3.2 qRT-PCR on candidate genes of interest 
 The effects of social environment on morphine-induced gene expression in the 
striatum were analyzed using a two-way ANOVA with housing and treatment as 
between-subjects variables with the fold change (ΔΔCt method) derived from the qRT-
PCR as the dependent variable, followed by Bonferroni post-hoc analyses. I found that 
there were several gene targets with significant interactions of housing and treatment 
(Figure 17). 
  
8.3.2.1 Forkhead Box J2 (Foxj2) 
Data presented in Figure 17A. Two-way ANOVA revealed no significant main 
effects of treatment (F(1,34) = 3.61, p=0.07) or housing (F(1,34) = 0.13, NS).  However, 
there was a significant interaction between housing and treatment (F(1,34) = 8.46, 
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p<0.01). Bonferroni post-hoc analysis revealed significantly higher expression levels in 
morphine only animals as compared to saline only animals (MOR vs. SAL, p < 0.01). In 
contrast, there was no significant difference in expression levels between the morphine 
cage-mates and saline-treated animals (MCM vs. SAL, NS).  Lastly, there was a trend 
for higher expression levels in the morphine only than the morphine cage-mate animals 
(MCM vs. MOR, p=0.1). 
  
8.3.2.2 Phosphatidic Acid-Preferring Phospholipase A1 (DDHD1)  
Data presented in Figure 17B. Two-way ANOVA revealed that there were no 
significant main effects of treatment (F(1,34) = 1.53, NS) or housing (F(1,34) = 2.48, 
NS).  However, there was a significant interaction between housing and treatment 
(F(1,34) = 8.06, p<0.01). Bonferroni post-hoc analysis revealed that there was 
significantly higher expression in the morphine only mice than the saline only animals 
(p=0.03). There was no difference in expression levels between the saline only and the 
morphine cage-mates. Moreover, morphine only mice exhibit higher expression levels as 
compared to the morphine cage-mates (p=0.02).  
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Figure 17. Genes that showed a significant treatment or housing × treatment interaction. 
Saline only, n = 9; saline cage-mates, n = 9; morphine cage-mates, n = 10; and morphine 
only, n = 10. * indicates significant differences from SAL; # indicates significant 
difference from MCM. Results are presented as means ± SEM. 
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8.3.2.3 Cyclin Dependent Kinase 12 (Cdk12) 
Data presented in Figure 17C.  Two way ANOVA revealed no main effects of 
housing (F(1,34) = 0.02, NS) or treatment (F(1,34) = 2.19, NS), but a significant housing 
× treatment interaction (F(1,34) = 4.85, p<0.05).  Bonferroni post-hoc analysis revealed 
significantly higher expression in the morphine only animals than the saline only group 
(p=0.04). There was no difference between the morphine cage-mates and saline-treated 
animals.  
  
8.3.2.4 G Protein Nucleolar 3 (Gnl3) 
Data presented in Figure 17D. Two-way ANOVA revealed no main effect of 
housing (F(1,34) = 3.36, NS), but a significant main effect of treatment (F(1,34) = 4.5, 
p<0.05). Also, there was a significant housing × treatment interaction (F(1,34) = 5.39, 
p<0.05). Bonferroni post-hoc analysis revealed significantly higher expression in 
morphine only as compared to the saline-treated animals (MOR vs. SAL, p = 0.02; MOR 
vs. SCM, p=0.04). There were no differences between the morphine-cage mates and the 
saline-treated animals (MCM vs. SAL, NS; MCM vs. SCM, NS).  Importantly, morphine 
only animals have significantly higher expression than morphine cage-mate mice (MCM 
vs. MOR, p = 0.02). 
 
8.3.2.5 Phosphodiesterase 12 (Pde12) 
Data presented in Figure 17E. Two-way ANOVA revealed a significant main 
effect of treatment (F(1,34) = 5.74, p=0.02). There was no significant main effect of 
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housing (F(1,34) = 2.29, NS), but there was a significant interaction between housing 
and treatment (F(1,34) = 5.93, p=.02).  Bonferroni post-hoc analysis revealed 
significantly higher expression in the morphine only animals compared to the saline-
treated mice (MOR vs. SAL, p = 0.01; MOR vs. SCM, p=0.04). There were no 
differences in expression levels between the morphine-cage mates and saline-treated 
animals (MCM vs. SAL, NS; MCM vs. SCM, NS).  Moreover, morphine only animals 
exhibit significantly higher expression levels than morphine cage-mates (MCM vs. 
MOR, p = 0.03). 
 
8.3.2.6 Dopamine 1 receptor (D1R) 
Data presented in Figure 17F. Two-way ANOVA revealed no main effects of 
housing (F(1,34) = 0.28, NS) or treatment (F(1,34) = 0.38, NS), but a significant housing 
× treatment interaction (F(1,34) = 4.69, p<0.05).  Bonferroni post-hoc analysis revealed 
significantly higher expression levels in the morphine only group compared to the saline 
only (MOR vs. SAL, p=0.01) and the morphine cage-mate groups (MOR vs. MCM, 
p<0.01).  
 
8.3.2.7 Rotatin (Rttn) 
Data presented in Figure 17G. Two-way ANOVA revealed no significant main 
effect of housing (F(1,34) = 0.206, NS), but there was a significant effect of treatment 
(F(1,34) = 6.39, p=0.02). There was no significant interaction between housing and 
treatment (F(1,34) = 0.04, NS). Bonferroni post-hoc analysis revealed a significant 
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increase in Rttn expression in both morphine-treated groups compared to both saline-
treated groups (p< 0.05). 
 
8.3.2.8 Other genes examined 
No significant differences between the experimental groups were observed in the 
expression levels of Pdgfra, Brd3, Irak1, Zfp518a, Farsa, Egfl7, Glce, Jag2, F5, βArr2, 
OtR, Ubn2, Klotho, Pdlim7, and Rabggtb. The results for these qPCRs are presented in 
Figure 18.  
 
 
Figure 18. Genes that did not show any significant effects. Saline only, n = 9; saline 
cage-mates, n = 9; morphine cage-mates, n = 10; and morphine only, n = 10. Results are 
presented as means ± SEM. 
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8.4 Discussion 
 Opioid misuse/abuse is a debilitating problem, and there is evidence for a 
bidirectional relationship between its abuse liability and social environment. Opioid 
addiction is a severe problem given that prescription opioids are the most commonly 
prescribed substances for moderate-to-severe pain, and their chronic use can lead to 
numerous consequences. The goal of the present experiments was to elucidate potential 
mechanisms underlying the observed role that social environment plays in the 
development of morphine dependence and reward in order to identify potential novel 
targets for pharmaceutical treatment. Therefore, an exploratory analysis was conducted. 
Using RNA-Seq, I investigated the interaction between social housing conditions and 
morphine treatment on gene expression levels in the striatum.  I observed that over 1200 
genes were altered by morphine when animals were housed only with other morphine-
treated animals (morphine only, MOR), as compared to saline-treated animals. However, 
only 121 genes were altered in morphine-treated animals housed with drug naïve 
animals (MCM), as compared to saline-treated animals, while only 61 of the altered 
genes are common between the morphine only and morphine cage-mate animals. This 
demonstrated that social housing conditions alter the effects of morphine on striatal gene 
expression. 
 In continuation of the RNA-Seq study, and in order to confirm its findings, I 
conducted qRT-PCR on genes of interest. I selected genes based on the direction of their 
differences and the magnitude of their fold changes, and others based on their relevance 
to opioid reward, dependence, and antinociception. Some of the targets revealed no 
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differences among groups, however, others produced some intriguing results.  Among 
these were Dopamine D1 Receptor (D1R), DDHD1 (Phosphatidic Acid-Preferring 
Phospholipase A1), Cdk12 (Cyclin-dependent kinase 12), Guanine nucleotide-binding 
protein-like 3 (Gnl3), Forkhead Box J2 (FoxJ2), and Phosphodiesterase 12 (Pde12). 
 
8.4.1 Dopamine D1 Receptor 
Medium spiny neurons encompass most - 95% - of the neurons in the striatum 
(Yager et al., 2015).  These neurons typically have two types, D1-receptor (D1R) 
expressing neurons in the direct pathway, and D2-receptor (D2R) expressing neurons in 
the indirect pathway (Nishi, Kuroiwa, & Shuto, 2011).  Therefore, I measured 
expression of dopamine receptors using qPCR.  Unfortunately, due to difficulties with 
primer design and qPCR parameters, I was unable to measure D2R gene expression.  
Nevertheless, I observed increased D1R expression in morphine only animals as 
compared to morphine cage-mates.  It is known that activity at D1R contributes to the 
rewarding/reinforcing effects of morphine, as antagonism of D1R in the striatum 
decreases acquisition of morphine CPP (Shippenberg, Bals-Kubik, & Herz, 1993; 
Shippenberg & Herz, 1988), including single-trial CPP acquisition, like that used in 
experiment 5 (Fenu et al., 2006). Also, D1R-null mutant mice do not develop locomotor 
sensitization to morphine (A. Becker et al., 2001), and do not acquire morphine CPP (Y. 
P. Wang et al., 2015). Moreover, striatal D1 receptors are important for attention to 
drug-related cues and reward sensitivity (Agnoli & Carli, 2011; Sharp et al., 1995). 
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Interestingly, administration of morphine has also been shown to cause induction 
of ΔFosB in the accumbens (Muller & Unterwald, 2005; H. L. Wang et al., 2005), a 
transcription factor that accumulates during repeated drug exposure, and has been linked 
to drug withdrawal. Activity at D1R in NAcc is important for the acute rewarding effects 
of drugs of abuse, including morphine.  However, in the dorsal striatum, which is 
important for habit formation and compulsive behavior, chronic exposure to morphine 
leads to induction of ΔFosB, and involves activity at D1R (Muller & Unterwald, 2005).  
ΔFosB is selective for D1R-expressing neurons, suggesting that D1R is critical for the 
development of addictive behaviors. Moreover, ΔFosB induction is more pronounced in 
adolescents, an age group that shows higher vulnerability to addiction, and is the focus 
of this dissertation.  Here, I show that D1R-expression is higher in the morphine only 
animals than in morphine cage-mates.  Increased levels of D1R-expression might 
correlate with the increased induction of ΔFosB that is observed following chronic 
exposure to morphine. 
There is a discrepancy between my findings and other findings in the literature.  
Georges et al. (1999) observed decreased expression of D1R in the rat striatum.  
However, their experimental design is quite different from mine, as they implanted 
morphine pellets for continuous exposure to morphine, and I intermittently administered 
morphine to the animals once a day.  Also, they did not observe any differences in 
locomotor activity between control animals and animals implanted with morphine 
pellets, while in previous experiments, there are drastic increases in locomotor activity. 
Thus, the differences in gene expression might represent differences in behavioral 
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response to the different morphine regimen used. This is given that a more continuous 
chronic regimen was shown to cause tolerance to the activating effects of opioids, while 
an intermittent injection procedure produces locomotor sensitization (Eitan et al., 2003). 
It could also represent an age-specific effect, given that Georges et al. (1999) only 
examined adult animals, while I focus on adolescents.  It has been shown that D1R 
density is increased in adolescent animals, as compared to adults (Creese, Sibley, & Xu, 
1992; Dwyer & Leslie, 2016).  Moreover, adolescents are more sensitive to D1 agonists, 
and display greater reward sensitivity than adults (Dwyer & Leslie, 2016).  Therefore, a 
difference between adolescents and adults in levels of D1R following morphine 
exposure is expected. 
 
8.4.2 Phosphatidic Acid-Preferring Phospholipase A1 
 DDHD1, or phospholipase A1, is often implicated in regulating mitochondrial 
dynamics (Baba et al., 2014).  Recently, DDHD1 was also shown to be a synthesizing 
enzyme of 2-arachidonoyl-LPI (LPI), an agonist for the orphan G-coupled receptor, 
GPR55 (Yamashita et al., 2010), which was previously identified as a cannabinoid 
receptor (Nevalainen & Irving, 2010; Yamashita et al., 2013).  Interestingly, GPR55 
antagonists show therapeutic potential in the treatment of neuropathic pain (Staton et al., 
2008).  GPR55-null, male mice show a reduction in hyperalgesia that developed using 
two models of neuropathic pain, Freund’s complete adjuvant and the nerve ligation 
model. Therefore, if there is less GPR55 activity, there may be less neuropathic pain.  
Because DDHD1 is a synthesizing enzyme of the GPR55 agonist, LPI, lower levels of 
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DDHD1 may result in less agonism of GPR55, and thus a reduction of hyperalgesia. In 
the present results, morphine cage-mate mice did not exhibit the increased levels of 
DDHD1 observed in morphine only mice. Previously, I have shown that morphine cage-
mate mice do not develop thermal hyperalgesia that was present in morphine only 
animals (refer to Chapter V). Therefore, there may be a link between DDHD1 levels and 
the development of hyperalgesia.  Future studies need to be done to understand if this 
link between DDHD1 and hyperalgesia does indeed exist.  Moreover, because there is a 
correlation between the antinociceptive and addictive properties of opioids (Bates et al., 
2016), I propose that there is a common mediator for the two – DDHD1 may be a 
component of this common mediator.  Nevertheless, additional work needs to be done to 
understand the role that DDHD1 may play in opioid reward and dependence. 
 Although no work has been done to directly connect DDHD1 and opioids, a 
recent study provides some support for a link between GPR55 and the µ-opioid receptor 
(oprm1), where morphine binds with high-affinity (Wolozin & Pasternak, 1981).  
Viudez-Martinez et al. (2017) examined the effects of cannabidiol, an anxiolytic 
compound found in the Cannabis sativa plant on ethanol reinforcement, as well as on the 
expression of genes related to reinforcement in the nucleus accumbens (i.e., ventral 
striatum).  It was found that cannabidiol treatment significantly reduced expression of 
GPR55 and oprm1 almost identically (Viudez-Martinez et al., 2017). While this is 
certainly not a causal link, these data suggest a relationship between GPR55 and oprm1.  
Future experiments should examine whether treatments that upregulate oprm1 also 
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induce an upregulation of GPR55, and if the upregulation of GPR55 also increases 
DDHD1 levels. 
 
8.4.3 Cyclin-dependent kinase 12 
 Another target of interest is Cyclin-dependent kinase 12 (Cdk12). Cdk12 was 
upregulated in morphine only animals as compared to morphine cage-mates.  Cdk12, 
like many cyclin dependent kinases, is important for regulation of the cell cycle, and is 
involved in transcription and posttranscriptional processes. Cdk12 is a regulator of 
transcription elongation (Bartkowiak et al., 2010; K. Liang et al., 2015).  Also, Cdk12 is 
important for genomic stability, as cells depleted of Cdk12 are sensitive to DNA damage 
(Blazek et al., 2011; Juan et al., 2016).  Cdk12 was also shown to be involved in the 
regulation of axonal elongation in cortical neurons (H. R. Chen, Lin, et al., 2014).  
Chronic morphine has been shown to alter presynaptic proteins (Abul-Husn et al., 2011; 
Berrios, Castro, & Kuffler, 2008). Interestingly, animals with established morphine self-
administration behavior exhibited an upregulation of genes involved in axonal 
development and outgrowth (Tapocik et al., 2013). More work should be done to 
understand the precise patterns of axonal alterations produced by morphine dependence, 
and how neuroplasticity-associated genes are involved. Here, I observed an increased 
expression of Cdk12 in morphine only animals compared to morphine-cage mates.  It 
has also been observed that morphine only animals display increased levels of morphine 
dependence as compared to morphine cage-mates.  This provides a potential mechanistic 
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link between the increased levels of Cdk12 reported here, and increases in morphine 
dependence. 
 Cyclin-dependent kinases, like Cdk12, typically require an association with a 
specific cyclin subunit.  Recently, it has been shown that Cdk12 most closely associates 
with cyclin K (Kohoutek & Blazek, 2012).  The cyclinK/Cdk12 complex is reported to 
be important for maintaining genomic stability for cell survival (Blazek, 2012; Blazek et 
al., 2011).  Cyclin K is also a transcriptional target of p53, a tumor suppressor protein 
(Mori et al., 2002). Mori et al. (2002) showed that cyclin K may begin to act on cell 
survival after being targeted for transcription, and activated, by p53.  Interestingly, p53 
is involved in the development of antinociceptive tolerance to morphine, as chronic 
exposure to morphine induces over-expression of p53 (Shoae-Hassani et al., 2011; 
Tsujikawa et al., 2009) and antinociceptive tolerance to morphine was blunted following 
administration of a p53 inhibitor (Tsujikawa et al., 2009). Therefore, p53 may be 
overexpressed in morphine only animals as compared to morphine cage-mates, which 
would explain their increased antinociceptive tolerance to morphine, and their increased 
levels of Cdk12. Future studies would need to examine think link further, as well as 
levels of p53 tumor suppressor protein in these groups. 
  
8.4.4Gnl3/Nucleostemin 
 Guanine nucleotide-binding protein-like 3, also known as nucleostemin, is a 
recently identified nucleolar protein that regulates cell cycle progression and has been 
implicated in modulation of p53 (Tsai & McKay, 2002).  Overexpression of Gnl3 acts 
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on murine double minute (MDM2) to prevent degradation of p53 (Dai, Sun, & Lu, 2008; 
H. Ma & Pederson).  While Gnl3 has yet to be linked to morphine-induced apoptosis, 
my results suggest that it may play a role in the increased dependence and reward that 
has been observed in morphine only animals.  I found that mRNA expression of Gnl3 
was significantly higher than all other groups, which provides further evidence for a role 
of regulators of the cell cycle in the differences produced by social environment.   
Because like Cdk12 it is involved in p53 signaling, this finding also suggests that there 
are differences in p53-induced apoptosis in the striatum among groups. Future 
experiments should examine this, as well as study levels of p53 activity in the striatum. 
 
8.4.5 Forkhead Box J2 
 FoxJ2 is a member of the fork head family of transcriptional activators; the 
expression of which starts very in embryonic development and is distributed widely in 
the adult (Granadino et al., 2000). I showed that FoxJ2 was upregulated in morphine 
only animals compared to morphine cage-mates. Recently, it was shown that 
overexpression of FoxJ2 in utero is lethal in some mice, and leads to hypertrophy of the 
heart in the few surviving adults (Martin-de-Lara et al., 2008).  Martin-de-Lara et al. 
(2008) also showed that FoxJ2 may be involved in the transcription of Cadherin 1, as 
FoxJ2 overexpression produced a phenotype similar to overexpression of this gene.  
Moreover, FoxJ2 binds to promoter regions encoding for Cadherin1 and activates their 
transcription. 
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Interestingly, cadherins have been shown to be differentially expressed based on 
substance history.  Higher levels of cadherin mRNA were observed in the hippocampus 
of mice with established oxycodone self-administration compared to those of yoked-
saline controls (Zhang et al., 2015). Similarly, levels of cadherins and protocadherins in 
the nucleus accumbens were increased following cocaine exposure and during cocaine 
withdrawal (Eipper-Mains et al., 2013). Therefore, cadherins may be involved in the 
acquisition and maintenance of drug self-administration behavior and dependence.  
While these findings do not directly implicate FoxJ2, the fact that FoxJ2 is involved in 
their signaling pathways suggests that it may be involved in drug-related behaviors. 
 
8.4.6 Phosphodiesterase 12 
 Phosphodiesterase 12 (Pde12) breaks phosphodiester bonds, as is typical of the 
phosphodiesterase family.  Also, like DDHD1, Pde12 is associated with the 
mitochondria, where it acts to regulate translation of RNA to protein (Rorbach, Nicholls, 
& Minczuk, 2011). Recently, Pde12 was identified as a negative regulator of 2’5’ 
oligoadenylate (OA) (Wood et al., 2015), which is activated by interferons, induces 
RNAse L, and binds to and degrades viruses upon infection (Silverman, 2007; Sim et al., 
2016).  Interferons are a group of proteins that are released upon sensing a pathogen (De 
Andrea et al., 2002). Relative to the present work, interferons are decreased in opioid 
addicts and individuals who use them chronically.  Chronic use of opioids often leads to 
immunosuppression (for review, see (Plein & Rittner, 2017)).  Also, I observed a trend 
for a significant difference between morphine only and saline only animals in expression 
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of Interleukin-1 receptor-associated kinase-1, which is involved in immune function 
(Deng et al., 2003). Moreover, morphine decreases RNAse L enzyme activity, an effect 
that was blocked with agonism of 2’5’ OA (Homan et al., 2002). 
In a series of experiments, Dafny and colleagues showed that interferons affect 
morphine dependence and withdrawal.  Animals that were chronically exposed to 
morphine and given interferon treatment exhibited a dampened withdrawal syndrome 
compared to those without interferon treatment (Dafny, 1983; Dafny, Zielinksi, & 
Reyes-Vazquez, 1983; Dougherty et al., 1987), an effect that occurred with multiple 
classes of interferons (Dafny & Reyes-Vazquez, 1985). Moreover, physical dependence 
to morphine produces an inhibition in interferon response (Lorenzo et al., 1987).   
 Phosphodiesterases have also been implicated in morphine reward.  
Phosphodiesterase 10A (Pde10A) is highly expressed in medium spiny neurons of the 
striatum. It was found that administration of a Pde10A inhibitor decreased acquisition, 
and accelerated extinction, of morphine CPP (Mu et al., 2014).  While Mu and 
colleagues did not directly examine Pde12, these findings suggest that the 
phosphodiesterase family can influence morphine CPP.  In the present experiment, I 
found that the morphine cage-mates do not exhibit the increased levels of Pde12 
observed in morphine only animals.  These animals also show decreased acquisition of 
morphine CPP, and accelerated extinction.  Therefore, it is possible that decreasing 
Pde12 would decrease acquisition of morphine CPP. 
 Because Pde12 negatively regulates OA, it is possible that increased levels of 
Pde12 correlate with decreased levels of OA and interferon activity.  Therefore, the 
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increased levels of Pde12 gene expression and decreased immune activity in the 
morphine only animals would correlate with the more severe withdrawal symptoms that 
I observe in this group.  Conversely, because morphine cage-mates do not exhibit the 
morphine-induced increase in Pde12 expression observed in morphine only animals, 
then interferon activity would be normal and they would display fewer withdrawal 
symptoms than the morphine only animals, which they do. It would be interesting to 
examine immune function among the different housing conditions to see if they differ. 
 I only investigated alterations in mRNA in this study, more work should be done 
to determine if the mRNAs explored here translate into proteins. Also, I analyzed 
changes in expression using homogenization of the whole striatum, thus future work 
should seek to reveal the precise locations of the alteration in these mRNAs, and their 
associated proteins, in order to develop a clearer picture of the present findings. 
Morphine has been shown to alter gene expression in the striatum. Here, I show that 
social housing conditions can affect these alterations, in that, for a variety of genes 
morphine cage mates show differential regulation as compared to morphine only 
animals.  This study suggests that the gene × environment interactions in altering striatal 
gene expression likely explain the effects of social environment on the abuse potential of 
opioids in adolescent mice. 
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CHAPTER IX 
GENERAL DISCUSSION AND CONCLUSIONS 
 
 The studies in the present dissertation provide evidence for a role of social 
environment on morphine sensitivity and morphine-induced behaviors in adolescent 
mice. The role of social environment in human drug abuse is well-known. Therefore, I 
sought to examine this in a rodent model.  Because social environment is influential 
during adolescence, the experiments described here focus on this age group. Animals 
were housed in the ‘only’ condition, or in the ‘mixed’ condition.  In the only condition, 
all animals in a cage were given repeated injections of the same treatment. However, in 
the mixed condition, half of the animals in a cage were given repeated injections of 
saline, and half of them were given repeated injections of morphine.   
 The goal of the first three experiments was to further investigate the role of social 
housing on morphine-induced behaviors.  Previously, it was observed that social 
environment affected sensitization to morphine-induced locomotor activation, as well as 
sensitization to morphine reward (measured by morphine CPP) (Cole et al., 2013; 
Hodgson et al., 2010). More specifically, there was a protective effect of being housed 
with drug-naïve animals during morphine exposure in adolescent mice.  In order to 
extend these observations, I examined whether or not social environment would affect 
the extinction of morphine CPP, spontaneous withdrawal symptoms following morphine 
cessation, and morphine antinociception. 
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 Given that social environment sensitized morphine only, but not morphine cage-
mate, animals to more readily acquire morphine CPP, I sought to examine, using a 
classical CPP procedure, whether social housing conditions would alter the acquisition 
and extinction of morphine CPP. In this experiment, mice housed in the morphine only 
condition acquired CPP faster as well as took significantly longer to extinguish 
morphine CPP than those housed as morphine cage-mates. While it took cage-mates 
longer to acquire CPP, they did eventually acquire it. However, they extinguish CPP 
readily using an extinction protocol of 30-minute extinction sessions. In striking 
contrast, the morphine only animals failed to extinguish morphine CPP using this 
extinction protocol.  Therefore, the memory of morphine reward appears to be less 
robust in morphine cage-mates than in morphine only animals. Because length of time to 
extinguish morphine CPP relates to increased drug reward (X. Ma et al., 2012), these 
data suggest that morphine only mice find morphine more rewarding than the morphine 
cage-mates. Also, these findings suggest that neural alterations involved in morphine 
memory may be more drastic in morphine only animals. Thus, the findings in this 
experiment show that being housed with drug-naïve animals attenuates the development 
of morphine reward in adolescent mice. 
The observation that social environment modulates morphine reward is exciting 
and quite relevant to human addiction. In addition, many addicts report that their 
continued use of opioids is not due to its rewarding properties, which have decreased, 
but rather to stave off withdrawal symptoms (Volkow et al., 2010).  Therefore, in the 
next experiment, I examined the expression of somatic withdrawal symptoms in 
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adolescent mice.  Animals that received morphine while housed with drug-naïve animals 
displayed significantly fewer withdrawal symptoms than those that were housed in the 
morphine only condition.  Because withdrawal symptoms correlate with the degree of 
morphine dependence, this finding indicates that morphine cage-mates develop less 
physical dependence on morphine than morphine only animals (Schulz & Herz, 1977).  
These results corroborate previous findings that morphine’s effects are more robust in 
morphine only animals than in morphine cage-mates. Because morphine reward and 
dependence are very relevant to human addiction, the results of these experiments 
suggest that, in adolescent mice, social environment may mitigate the development of 
addiction. 
 Opioids are the most commonly used substances for pain. Reward and 
dependence are the focus of this dissertation, but it was also important to examine if 
social housing conditions in the present paradigm affected morphine antinociceptive 
processes.  Moreover, the development of paradoxical pain symptoms, like tolerance and 
hyperalgesia, is related to morphine dependence (Ueda & Ueda, 2009). There is 
evidence that implies that morphine analgesic tolerance and physical dependence may 
share some similar mechanisms (D. Y. Liang et al., 2007). Additionally, animals that 
show tolerance to morphine analgesia also show increased jumping behavior, which is 
indicative of dependence and relevant to this dissertation (D. Y. Liang et al., 2006). 
Therefore, I studied if social environment affects morphine-induced analgesic tolerance 
and hyperalgesia. 
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In experiment 3, I used four different measures of morphine analgesia: tail 
withdrawal, sensitivity to mechanical and cold allodynia, and thermal nociception, as 
measured by the hot plate test.  I found that social environment did mediate the alteration 
of nociceptive processes following repeated morphine exposure.  Morphine only mice, 
the mice that were more vulnerable to morphine reward and physical dependence, 
developed antinociceptive tolerance that was more robust than the tolerance that was 
developed by morphine cage-mates.  Similarly, these animals were the only group to 
develop opioid-induced hyperalgesia.  Therefore, the results of this study indicate that 
social environment not only affects the neurobiological processes underlying morphine 
reward and dependence, but morphine antinociception as well.  This provides more 
support for previous findings, and also suggests that the effects of social environment are 
diverse.   
My findings are in line with previous studies that demonstrated the impact of 
social factors on nociceptive processes (for review see (Morales-Rivera et al., 2014)). 
Social play deprivation and peer-rejection during adolescence were demonstrated to 
modulate pain reactivity in rodents (E. H. Schneider, Neumann, & Seifert, 2014). 
Moreover, opioid antinociception is affected by social stress (Huhman et al., 1991; 
Miczek et al., 1982; Rodgers & Hendrie, 1983). Lastly, the observation of a cage-mate in 
pain or the observation of a cage-mate who does not experience pain increases or 
reduces, respectively, the responses to pain in their pain-inflicted cage-mates (Langford 
et al., 2006). This suggests that social environment can have profound effects on 
neurobiological processes underlying pain mechanisms.   
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The previous studies offer evidence that supports the notion that social 
environment affects morphine reward, dependence, and antinociception.  Specifically, 
they showed that being housed with drug-naïve animals during morphine exposure 
provides protection from the effects of morphine.  However, all of the previous 
experiments focus on behavior, with little exploration of underlying mechanisms.  The 
only differential experimental manipulation between morphine only animals and 
morphine cage-mates is the conditions in which they were housed.  Thus, the findings 
suggest that the differences arise due to an interaction between social environment and 
opioid treatment.  It is possible that mechanisms that mediate social interaction are 
involved in the results seen here. Therefore, the next set of studies sought to determine 
those neurobiological processes. In experiment 4, I focus on an affiliative behavior in 
rodents, social grooming, and its underlying mechanisms, while in experiment 5, I focus 
on one of the most commonly implicated peptides in social interaction, vasopressin. 
Lastly, in experiment 6, I conduct a general exploration of possible genetic mechanisms 
using high-throughput, next-generation genomic sequencing and qPCR. 
I was interested in deciphering possible behavioral mechanisms by which the 
protective effect that I observed might be conferred to morphine cage-mates. 
Observational data in the laboratory suggests that differential patterns of social 
interaction between animals housed in the morphine only condition, and those housed as 
morphine cage-mates might be responsible.  One form of affiliative social behavior in 
the rodent is social grooming. Recently, a novel neuronal subtype involved in social 
grooming, MRGPRB4+ neurons, was discovered (Vrontou et al., 2013). In this study, 
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Vrontou et al. (2013) developed a DREADD model to explore the behavioral effects of 
manipulating MRGPRB+ neuronal activity.  They were able to show that activation of 
these neurons produced reward in juvenile mice.  Therefore, using DREADD 
technology, I manipulated these neurons and the sensation of social grooming in 
morphine-treated animals in the different housing conditions. More specifically, I 
activated the sensation of grooming in morphine only animals and inhibited it in 
morphine cage-mates. 
I found that inhibition of the sensation of social grooming in morphine cage-
mates increased morphine dependence.  These results suggest that reducing the sensation 
of social grooming by decreasing activity at MRGPRB4+ neurons has the ability to 
affect the previously observed social housing effect.  Moreover, there was a trend that 
did not reach significance in these animals for increased time to extinguish morphine 
CPP. Conversely, activating MRGPRB4+ neurons did not affect morphine dependence, 
but it did decrease acquisition of reward in morphine only animals. However, it did not 
affect extinction of CPP. This may be due to over activation of these neurons, which 
could have induced excessive stimulation to these animals that was similar to social 
crowding, a form of social stress (Beery & Kaufer, 2015).  
There are other possible behavioral mechanisms that may confer the observed 
protective effect to the morphine cage-mates.  One such mechanism may be social 
learning. While social learning has not been studied in opioids, there are extensive data 
that show that it is relevant to the acquisition of drug-taking behaviors.  The effect of 
peer drug use on the social transmission of ethanol intake has been explored using the 
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“observer-demonstrator procedure” (Hunt & Hallmark, 2001; Hunt, Lant, & Carroll, 
2000).  In these studies, a demonstrator rat is administered ethanol, and observed by a 
cage-mate, and then this cage-mate is examined for ethanol consumption 30 minutes 
later.  Both preweanling (Postnatal day 8-12) (Hunt et al., 2000) and periadolescent 
(Hunt et al., 2001) observer rats that were exposed to an intoxicated peer voluntarily 
consumed more ethanol than did rats that were exposed to sober peers.  Moreover, the 
observer rats only increased their ingestion of ethanol, not a control solution, which 
suggests that only ethanol preference was transferred, and not a preference for general 
consumption.  Therefore, the effects of morphine may have been compounded in 
morphine only animals because of their interaction with only other morphine-dependent 
animals. However, the morphine cage-mates would be spared from this because of their 
interaction with only one other morphine-dependent animal, as well as their interactions 
with drug-naïve animals. One way to examine this would be by preventing the ability of 
the animals to interact, or to prevent them from being able to transmit information by 
inducing anosmia (i.e., blocking their sense of smell).  Indeed, preference for nicotine 
has been shown to be socially transmitted through carbon disulfide, a compound present 
in the exhaled breath of rodents (T. Wang & Chen, 2014).  Therefore, examining the 
social transmission of opioid preference may be a worthwhile venture in the future. 
 The reasoning behind considering social grooming was very sound because 
adolescence is the period in development when social interaction is its most salient.  
Moreover, in rodents, social play behaviors occur more frequently than any other 
developmental stage (Vanderschuren, Spruijt, et al., 1995). Also, in adolescent rats, 
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opioids seem to decrease social play (Panksepp et al., 1985).  Morphine decreases social 
investigation in mice (Kennedy et al., 2011; Landauer & Balster, 1982), and opioid 
withdrawal increases social aggression (Kantak & Miczek, 1986, 1988). Therefore, it 
may be that there are decreased play behaviors in morphine only cages than in mixed 
cages.  In continuation of the above reasoning, in this next experiment I sought to 
understand the role of vasopressin in the social housing effect because of its importance 
in social recognition and social play behavior (Veenema, Bredewold, & De Vries, 2013). 
In agreement with previous literature, I found that blockade of AVP activity at the V1b 
receptor decreased morphine CPP acquisition in morphine only animals, while having no 
effects in morphine cage-mates.  Consistent with these results, AVP gene expression in 
the striatum was significantly higher in morphine only animals as compared to all other 
groups, which suggests a role for AVP in the effect that social environment has on drug 
reward and dependence. 
 In the final experiment, I examined gene expression in the striatum among all of 
the experimental groups and observed that morphine has markedly larger effects on 
alteration in striatal gene expression in morphine only animals compared to all other 
experimental groups, including morphine cage-mates.  This confirmed my hypothesis 
that social environment interacts with the ability of morphine to regulate genetic 
mechanisms.  The genes that were identified had various functions, including activity as 
signaling mechanisms, transcription factors, and enzymatic activity. 
 The goal of these experiments was to identify mechanisms that may have been 
involved in the observed interaction between social environment and morphine treatment 
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as related to the addictive properties and pain-relieving effects of opioids.  In experiment 
6 I identified, and confirmed with qPCR, multiple gene targets that were significantly 
increased in the morphine only animals.  Two of these genes, Cdk12 and Gnl3, interact 
with the tumor suppressor gene, p53.  There is emerging evidence that suggest that p53 
might mediate some of the effects of morphine in morphine-dependent animals.   
Morphine dependence has been shown to produce apoptosis in many brain 
regions, including the striatum and other parts of the reward circuitry (Katebi et al., 
2013).  Previous data suggest that p53 is elevated during apoptotic states, and its activity 
may signal apoptosis, as levels of p53 were increased during NMDA-mediated apoptosis 
in striatal medium spiny neurons (Qin et al., 1999). Therefore, p53 might produce 
apoptosis in morphine-dependent animals. CyclinK/Cdk12 complex and Gnl3 are 
involved in p53 cell signaling to produce apoptosis.  Because levels of these genes are 
lower in morphine cage-mates than morphine only animals, this may correlate with my 
observation that morphine dependence and reward are decreased in morphine cage-
mates.  Nevertheless, more work needs to be done in order to determine whether or not 
levels of p53 activity, and apoptosis in striatal neurons, differ between these groups. 
 Interestingly, p53 expression has been shown to be altered by social enrichment.  
Typically, prenatal alcohol exposure leads to an increase in p53 expression in the 
striatum of adolescent rats.   However, adolescent animals exposed to social enrichment 
displayed decreases in levels of striatal p53 (Ignacio, Mooney, & Middleton, 2014).  
While morphine and alcohol are different compounds that act at different receptors, they 
share the ability to alter function of dopaminergic neurons in the striatum to produce 
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reward. Moreover, both morphine and ethanol induce p53 activity.  Therefore, Ignacio et 
al. (2014)’s findings with ethanol may relate to the present results with morphine, and 
suggest that social environment can attenuate the expression of signaling molecules that 
mediate the effects of drug exposure. 
 In experiment 6, I also measured levels of dopamine D1 receptor (D1R). D1R is 
often implicated in drug reward, and the association of drug cues with a drug, including 
the acquisition of CPP.  Moreover, excess dopamine activity, via D1R, was previously 
shown to induce apoptosis in juvenile mice (J. Chen et al., 2009; Iwatsubo et al., 2007), 
indicating a possible relationship between apoptotic processes and D1R levels.  
Similarly, methamphetamine, a potent agonist of dopaminergic activity, was shown to 
increase p53 activity in the striatum (Asanuma et al., 2002).  Nevertheless, a relationship 
between morphine exposure, p53, and D1R has not been explored, but is a potential 
explanation for the effects seen here. 
 There is also a relationship between dopamine activity and AVP in the striatum. 
AVP has been shown to affect dopamine concentration, as antivasopressin serum, which 
lowers AVP levels, decreases dopamine turnover in the striatum (Tanaka et al., 1977). 
Moreover, similar to effects seen with morphine, intra-striatum administration of AVP 
increases dopamine turnover there, suggesting that AVP affects dopamine release in the 
striatum (Sugrue, 1974; van Heuven-Nolsen & Versteeg, 1985).  It is known that chronic 
administration of morphine leads to increases in dopamine release in the striatum (Bosse 
& Kuschinsky, 1976) – AVP may be involved in this increase. Also, low levels of AVP 
enhanced the dopamine-induced activation of adenylate cyclase in the striatum 
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(Courtney & Raskind, 1983).  Activity of adenylate cyclase has been shown to be 
increased in morphine-dependent states (Shijun et al., 2009), so it is possible that the 
increased AVP in the striatum is also associated with the augmentation of adenylate 
cyclase activity seen in morphine-dependent animals.  
 If the increased level of AVP in the striatum is related to increased dopamine 
release there, then this may be a potential mechanism by which social housing affects 
morphine CPP.  The mesolimbic circuitry is involved in drug reward.  It may be the case 
that there is decreased dopaminergic activity in the striatum in morphine cage-mates.  
Indeed, I found decreased levels of D1R in the striatum of morphine cage-mates. Future 
studies should explore whether or not dopamine activity differs between morphine only 
animals and morphine cage-mates, as well as whether or not levels of other dopamine 
receptors differ between these groups.  
While I was thorough, there are many other candidates that were not examined 
here.  One such candidate would be oxytocin. Oxytocin induces profound prosocial 
effects in both humans and non-human animals, including increases in the salience of 
social stimuli, as well as increases in the time spent interacting with conspecifics in a 
social interaction test (Domes et al., 2007; Lukas et al., 2011). Conversely, oxytocin and 
oxytocin-receptor (OT-R) knockout mice show deficits in social recognition (Choleris et 
al., 2006; Ferguson et al., 2000; Takayanagi et al., 2005).  Moreover, it has been shown 
to be modulate opioid-induced reward and dependence (Brown et al., 2005; Kovacs, 
Borthaiser, et al., 1985; Kovacs et al., 1987).  Also, as mentioned in the Discussion for 
experiment 4, oxytocin is activated during social grooming, and may be a downstream 
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mechanism by which grooming exerts its rewarding properties. Nevertheless, I was not 
able to report any differences in oxytocin activity here.   There were technical difficulties 
that lead to low amplification of oxytocin in the qPCR.  Moreover, while I was able to 
measure oxytocin receptor gene expression, I found no differences among the groups.  
This could be due to the fact that oxytocin receptor expression is not very high in the 
striatum (Ostrowski, 1998).  Nonetheless, future studies should measure oxytocin levels 
in the striatum, or other parts of the brain, including hypothalamus and amygdala.  
It is also interesting to note that here I identify genes in which expression levels 
differ between saline only and saline cage-mate animals.  Previous studies show that 
saline cage-mates develop “sensitization” to morphine, as compared to saline only 
animals (Hodgson et al., 2010).  Moreover, saline cage-mates acquired morphine CPP 
after a single conditioning session with 40 mg/kg dose, but not saline only animals (Cole 
et al., 2013). Moreover, saline cage-mates demonstrated altered testosterone plasma 
levels similar to morphine-treated animals that were not observed in saline only animals 
(Hofford et al., 2011). This data indicates that the association with morphine-treated 
animals increases the abuse liability of opioids.  Thus, the identification of genes, in the 
present dissertation, that are altered in saline cage-mates animals might explain the 
increased abuse liability in this group. However, these effects were not further studied 
here and should be explored in-depth in future studies. 
The present experiments added to a body of work that characterized morphine-
induced behavior in adolescent rodents housed in different social conditions. Therefore, 
these studies provided further support for the effect of peer influences on morphine-
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related responses.  Moreover, the experiments explored potential mechanisms for these 
peer influences, and identified possible avenues for further study on the effects of social 
environment on the development of drug abuse in adolescents. Unfortunately, treatments 
for adolescent drug addiction are lacking. Opioid use remains a major issue, and the 
present data may present avenues for potential development of new treatments for 
adolescent opioid addicts.   
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